An investigation of possible inhibitors for D-amino acid oxidase by Delos, Sue Ellen
W&M ScholarWorks 
Dissertations, Theses, and Masters Projects Theses, Dissertations, & Master Projects 
1979 
An investigation of possible inhibitors for D-amino acid oxidase 
Sue Ellen Delos 
College of William & Mary - Arts & Sciences 
Follow this and additional works at: https://scholarworks.wm.edu/etd 
 Part of the Biochemistry Commons 
Recommended Citation 
Delos, Sue Ellen, "An investigation of possible inhibitors for D-amino acid oxidase" (1979). Dissertations, 
Theses, and Masters Projects. Paper 1539625081. 
https://dx.doi.org/doi:10.21220/s2-yttj-w654 
This Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M 
ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 
AN INVESTIGATION OF POSSIBLE INHIBITORS FOB D-AMING ACID OXIDAS
\ V
A Thesis 
Presented to 
The Faculty of the Department of Chemistry 
The College of William and Mary in Virginia
In Partial Fulfillment 
of the Requirements for the Degree of 
Master of Arts
APPROVAL SHEET
This thesis is submitted in partial fulfillment of 
the requirements for the degree of
Master of Arts
sLLt. Ijjl
Sue Ellen Delos, Author
Approved
Randolph A. Coleman, Ph.D.
Melvyn D. Schiavelli, Ph.D
David W. Thompson, Ph.D.
To My Family
TABLE OF CONTENTS
Acknowledgements ...................  * . . . . . . .  . viii
List of Figures and Schemes.............   ix
Abstract ........... .   . . . . . . . . . . . .  x
I. INTRODUCTION  ................................. . . 2
A. Scope of the Project and Thesis.  ................. . 2
B. Chemistry of DAAO........ ............................3
1. Biological Role. . . . .  .......................  3
2. Inhibition  ................................ 3
3. The DAAO Reaction and Kinetics..........   5
U. The Reaction Path................................ 8
5. The Nature of the Enzyme— Substrate Complex........ 10
6. The Form of the Product Released . . . . . . . . . .  12
7. Oxidation vs. Dehydrogenation.  ............15
8. Competative Inhibition.......................... 16
9. Irreversible Inhibition.  ...................17
a. Propargylglycine . . . ...................... 17
b. Nitroethane Anion.  .................   21
C. The Chemistry of Flavin............ ................22
1. The Geometry of Flavin.......................... 22
2. The Flavin«r*Substrate Interaction .  .............. 2k
3. Deazaflavin...................................2 o
iv
D. Suicide Inhibition . . . . . . . . . . .  .............  30
1. 3-Decynoyl-N-Acetylcysteamine......................31
2. Other Acetylenic Inhibitors........................33
3. 3-Nit r opr op ionate.......................  So
U. 2-Hydroxy-3-Butynoate.  ...............38
a. Lactate Oxidase.  ..........   38
b. Other Enzymes.  ...................   k6
5. Justification of the Choice of Inhibitors for DAAO . U8
II. ’MATERIALS AND METHODS..........       50
A. Synthesis of n-Dibutylt art rate............   50
B. Synthesis of n-Butyl Glyoxalate........................ 51
1. Periodic Acid Method.........    51
2. Lead Tetraacetate Method...................   51
3. Sodium Periodate Method..........   52
C. Grignard and Related Reagents: Preparation and Use . . .  52
1. Lithium Acetylide......................  52
2. Methyl Magnesium Iodide..........     53
3. Ethynyl Magnesium Halide......................... 53
h. Butyl 2-Hydroxy-3~Butynoate........................5^
a. From Ethynyl Magnesium Halide.................. 5^
b. From Lithium Acetylide........................ 55
5. Ethyl 2-Keto-3-Butynoate......................... 55
Do Synthesis of Butyl 2-Tosyl-3-Butynoate ............... 56
E. Preparation of Butyl 2-Chloro-3*-Butynoate............... 57
v
1. In Diethyl Ether with Pyridine................... 57
2. In Isopropyl Ether  ..................... . . 57
F. Alumina Column Chromatography............. 58
Go Attempts to Prepare Butyl 2-Amino-3-Butynoate. ........ 58
1. With Ammonia..........   58
a. Preparation of Cuperous Chloride  ............ 59
h. Preparation of Amine.......... .  ..........59
2. Cyanohorohydride on Ethyl 2-Keto-3-Butynoate . . . . 60
3. Gabriel Synthesis. . . . . . . . . . . . .  .......  6l
a. Preparation of the Phthalimide . . . . . . . . .  6l
b. Hydrozinolysis of the Phthalimide..............6l
H. Hydrolysis..................   62
1. Akaline...................   62
2. Acidic................  . . . . . . . .  62
3. Transesterification. . ............  . . . . . . .  63
I. Enzyme Assays— Irreversible Inhibition . . .  .........6k
1. Inhibition . . . . . . . . . . . . .  ............  6k
a. Solutions. . . . . . . . . . . . . . . . . . . .  6k
b. Procedure..........   65
2, Pyruvate Assay................  65
a. Solutions...................   65
b. Procedure..........   65
III. RESULTS AND DISCUSSION................  67
A. Preparation of Butyl-2-Hydroxy-3-Butynoate ...........  67
1. Preparation of n-Butyl Glyoxalate................. 67
2. Preparation of Butyl 2-Hydroxy-3-Butynoate........ 68
vi
Be Preparation of Butyl 2-Tosyl~3~Butynoate .  .......... 70
C. Preparation of Butyl 2-Chloro-3-Butynoate« . . . . . . .  71
1. Synthesis. . . ................ . . . . .  f ... 71
2. Separation of Butyl 2-Chloro-3“Butynoate from Butyl
2-Hydroxy-3-Butynoate. . . .......  . . . . . . . .  71
D. Attempts to Make 2-Amino-3-Butynoate  ........   73
1. Using Ammonia..............  73
2. The Cyanoborohydride Reaction..........   7^-
a. Ethyl 2-Keto-3-Butynoate.........    j6
b. The Cyanoborohydride Reaction. . . . . . . . . .  78
3. The Gabriel Synthesis..........   78
a. Preparation of Butyl 2-Phthalimido-3-Butynoate . 80
b. Hydrazinolysis of Butyl 2-Phthalimido-3- 
Butynoate. . . . . . . . . . . . . . . . . . . .  80
E. Hydrolysis . . . . . . . . . . . . .    . . . . .  80
F. Enzyme Inhibition. . . . . .    . . . . . . . . .  8l
1. Chloro Compound.  ..........   8l
2. Oxalate Inhibition  ..........   8U
IV. CONCLUSIONS AND PROPOSALS FOR FURTHER STUDY............. 87
V. FIGURES AND SCHEMES............      91
References...................     101
vii
ACKNOWLEDGEMENTS
The author wishes to thank Dr. Randolph Coleman for his 
guidance in this project and Dr s. Melvyn Schiavelli and David Thompson 
for their careful reading and criticism of the manuscript. The author 
also thanks Ms. Louise Ramey for drawing the figures contained in 
this thesis, and Mrs. Dianne Fannin for her careful typing of this 
manuscript.
The author is particularly grateful to her children for 
all their help at home, allowing this project to be possible, and to 
her husband for his unflagging support.
LIST OF FIGURES AND SCHEMES
Figure 1 The two biological forms of flavin.
Figure 2 The oxidized, semiquinone and reduced states of flavin
and their absorption maxima.
Figure 3 Changes in the DAAO spectrum during catalysis.
Figure U The geometry of oxidized and reduced flavin.
Figure 5 Orbital overlap for a carbanion-fiavin adduct.
Figure 6 Inhibition of DAAO by hydrolysate from Path I, Scheme III
Scheme I The fate of propargylglycine during oxidation by DAAO.
Scheme II Mechanism proposed for flavin-catalyzed oxidation of
nitroethane anion.
Scheme III Separation of butyl 2-chloro-3-butynoate from 2-hydroxy-
3-butynoate* hydrolysis and inhibition results.
ABSTRACT
This thesis describes the preparation of several a-sub­
stituted butynoic acids and their inhibition of D-Amino Acid Oxidase.
A strong time-dependent inhibitor was found. Three new compounds have 
been prepared as intermediates in these reactions: ethyl 2-keto-3-
butynoate, butyl 2-tosy1-3-butynoate and butyl 2-phthalimido-3*-butynoate. 
Inhibition by diethyl oxalate is also described.
x
AN INVESTIGATION OF POSSIBLE INHIBITORS FOR D-AMINO ACID OXIDASE
I. INTRODUCTION
A. Scope of the Project and Thesis
It has been the purpose of this project to identify likely 
suicide inhibitors for D-Amino Acid Oxidase (DAAO), to attempt to 
synthesize these substances and to test their inhibition qualities 
in vitro.
A thorough search of the literature provided information 
on the reaction of DAAO, and the nature of the likely enzyme-substrate 
complex. With this understanding, suicide inhibitors for other 
enzymes were studied and a comparable class of substrates for DAAO 
identified. 2-Amino-3-butynoate and other a-substituted 3-acetylenic 
acids looked most promising as compounds most likely to be suicide 
inhibitors for DAAO. The inhibition of DAAO by several substances 
prepared during the course of this project has been studied and a very 
powerful, time-dependent inhibitor was found.
The first section of this thesis summarizes what is known 
about the DAAO reaction, the nature of the substrate-enzyme complex, 
and information on suicide inhibition used to decide upon an appro­
priate series of compounds to prepare. Section II describes the actual 
experiments performed. Section III discusses the results and implica­
tions of these experiments. Section IV reviews what has been accomplished 
and discusses possible future work.
2
3B. The Chemistry of DAAO
1. Biological Role
D-Amino Acid Oxidase (DAAO) was first discovered in 1938 "by 
Warburg and Christ ean\ Its presence in large quantities in pig liver 
and kidney lead to its easy isolation and widespread use as a model 
flavoenzyme. It is also used in synthetic work to purify L-amino acids 
by selectively destroying D-amino acids in a racemic mixture. However, 
the exact biological function of this enzyme remains elusive. It is 
thought that DAAO may have some role in the immune system since it 
could destroy the D-amino acids that comprise bacterial cell walls. A 
possible role for this enzyme in lipid metabolism has also been 
postulated^.
In addition to its presence in liver and kidney, DAAO is found
in the brain. Patek believes it may be used to remove glycine which
3is found m  modest concentrations m  the cerebellum . However, glycine 
is not a particularly good substrate for DAAO. This project was under­
taken to provide one step on the road to determining the biological 
role of DAAO.
2. Inhibition
To determine the role of an enzyme in_ vivo, one usually 
either removes it or destroys its activity, then observes what reactions 
do not take place in its absence. To remove DAAO requires destruction 
of the in vivo system. Therefore, some method of destroying its 
activity in_ vivo without harming other components of the system is 
desired. To this end one requires an inhibitor that: (l) is specific
for the enzyme in question, (2) has easy mobility from the point of
kinjection to the position of the enzyme, and, (3) does not react with 
other compounds before or after enzyme interaction. We shall concentrate 
on the design of a substrate that meets criteria (l) and (3).
Inhibition has been extensively exploited in the last two 
decades to study enzyme mechanisms and enzyme roles in vivo. Several 
types of inhibition have been characterized:
(1) Competitive inhibition: The inhibitor competes with
normal substrate for reversible binding at the active site. This changes 
the apparent (the dissociation constant of the enzyme-substrate com- 
plex) of the enzyme system, but ^ remains constant since the enzyme 
can be saturated with excess substrate, effectively excluding inhibi­
tor from any binding sites.
(2) Noncompetitive inhibition: Reversible binding of the
inhibitor does not interfere with substrate binding but alters the rate
of the reaction so that V is never reached. The rate of substratemax
binding is unaffected.
(3) Uncompetitive inhibition. The inhibitor binds reversi- 
bly in such a way that both the ability of the substrate to bind and 
the ability of the enzyme to catalize reaction are altered.
(10 Irreversible inhibition: Inhibition in any of the above
manners except forming a permanent covalent bond. This bond is judged
to be permanent when it is stable to dialysis, chromatography and
5-7other nondegradative physical methods.
It is this last form of inhibition, irreversible inhibition, 
that we are interested in. We wish to find a component that will 
irreversibly bind to DAAO, bind at the active site, and prevent any 
enzyme activity. Furthermore, we wish it to bind in such a way that
it has no chance to undergo spurious reactions "before or after interac­
tion with the DAAO. We also wish to have an inhibitor that does not 
react with another species before finding the target enzyme. Suicide 
Substrates are special substrates that require alteration by a target 
enzyme before they become inhibitors of that enzyme. Some experimental 
criteria necessary for suicide inhibition are^ :
(1) Loss of activity must be (a) first order, and, (b) time- 
dependent . If inactivation is time-dependent the enzyme has probably 
been covalently modified. First order kinetics indicate that inacti­
vation has occurred before the inactivator had a chance to be released 
from the.enzyme active site.
(2) The rate of inactivation (K. ) must be proportionalmstcx
to the concentration of the inhibitor at low concentrations of inhibi­
tor and independent of the concentration of inhibitor at high concentra­
tions. That is, the enzyme-inhibitor interaction must be competitive 
with the substrate and must display saturation kinetics, both necessary 
phenomena if inhibition is at the active site.
(3) K. . must decrease as the concentration of normalmact
substrate increases. This is also a necessary consequence of inhibitor 
binding at the enzyme active site.
{b) The binding must be irreversible.
3. The DAAO Reaction and Kinetics
What properties of DAAO can be exploited in designing a 
specific inactivator? Suicide Substrate criteria (2) and (3) require 
that binding be at the active site of the enzyme. Therefore we wish 
to understand as much as possible about the active site of this enzyme;
6its structure, the reactions it catalyzes, and the changes occurring 
at the active site during catalysis. Since DAAO has been used as a 
model enzyme in much flavoenzyme research, a great deal has been learned 
about its active site.
DAAO is a flavoenzyme. It contains flavin in the form of 
flavin adenine dinucleotide (FAD) (Fig. l) as. coenzyme. The protein-
g
aceous apoenzyme has a high basic amino acid content . The monomer has
9—11a molecular weight of about 38,000, with 1 FAD for each monomer 
12unit . This flavin is intimately involved in enzyme catalysis. Spec- 
13tral studies show that it oscillates between its fully oxidized and 
fully reduced states during the catalytic reaction (Fig. 2). DAAO 
catalizes the oxidation of D-amino acids:
m 2 m
I DAAO H . ■ .
R-C-C00H + 02 Jr? r>RC-C00H + H202 (la)
H [SH] [P]
m  o
II HP0^ H
RCC00H — —^ >>RCC00H + ITH3 (lb)
where (la) is the enzymatic oxidation of substrate and (lb) is
the nonenzymatic hydrolysis to the final product. The reaction can
lU
also be run in reverse under anaerobic conditions
Careful spectrophotometric and kinetic studies indicate that 
the specific stepwise reaction for flavoprotein oxidases can be 
represented as follows
That is, oxidized enzyme, Eq, combines with reduced substrate, [SH].
The enzyme oxidizes the substrate while itself being reduced, giving 
tfthe complex E ...P. At this point the enzyme has two pathways available 
■to it. It can release oxidized substrate (P), then accept oxygen to 
return to its activated state (loop A) as one might intuitively expect. 
.Or the enzyme-substrate complex can react with 0^  before the substrate 
is released (loop B). Figure 3 shows typical spectra for DAAO in its 
oxidized (Eq), reduced (E^ ), and complexed (E^ .-.P) forms.
The complete steady-state rate equation for equation 2 is:
[EtJ 1 k-lk-2
T  = + i^ TsT + k1k2(k3+k6[o2][s])
+  k ^ k ^ ( k 2 + k _ 2 ) [ 0 2 ] + k 2 ( k 3 k ^ + k ^ k g [ 0 2 ] ^ [ O g l + k g k g k ^ k ^
k2kUk5kT(k3~*"k6[0^])[©2  ^ (3)
This rather unwieldy equation can be simplified by the method of Dalziel 
into
IT
A *1 *2 *12
V • *0 + [s] + Top" [s][02]
8where the are functions of the rate constants, and in particular,
4>o  ^is the maximum turnover number. As can be shown, (J).^ usually = 0
13 18because k- and/or k _ = 0 * (see equation (3)) so that (U.) becomes
— d  —X
[E^ l ^  <p2
~ V  = *0 + IsT + To^T (5)
15giving straight line kinetics.
k. The Reaction Path
DAAO reacting with basic amino acids (especially aspartic 
and glutamic acids) follows loop A. k^  »  k  ^so no E^.-.P can be 
detected. However, when nonbasic amino acids are oxidized by DAAO, 
no correlation is observed between <j>  ^and and k^  and k^  of loop A; 
loop B must be operative instead. 0^  must react directly with E .. .P 
and dissociation of oxidized substrate from reoxidized enzyme, k^., 
must be the rate limiting step.
That loop B is indeed the proper path of equation (2) for
most DAAO reactions was finally shown by Porter, Voet and Bright in 
ida classic paper. Using stopped flow kinetics and inhibitors of the 
oxidized enzyme, they were also able to measure k^ and k^..
Either loop in equation (2) can be divided into two 
%-reactions. In the reductive %-reaction (RHR), the substrate is 
oxidized and the flavin of DAAO is reduced. Under anaerobic conditions 
the reaction stops at this point. If 0^ is then added in a second step 
the oxidative %-reaction (OHR) can take place. In this step the enzyme 
is reoxidized to its active state. In a stopped flow apparatus, two 
reaction mixtures (enzyme and substrate) simultaneously enter a
9reaction chamber and the course of the reaction is monitored spectro-
photometrically. In double stopped flow experiments this first reaction
is allowed to reach equilibrium, then a third solution is injected (in
this case Og) and the next reaction, the re-oxidation of enzyme, is
monitored. (Because E ...P and E ...P are only transient intermediates,r o
they cannot be used as initiating reagents in the simpler single stopped 
flow experiments.)
To measure kg, benzoate, a strong competitive inhibitor of
19E , was added with the Cu mix. Benzoate binds with the E formed o 2 o
in the OHR so that the reduction of enzyme is prevented and only the 
OHR takes place. The Eq-I complex is spectrally indistinguishable from 
Eq and E^...P, and it is formed quickly compared to kg and k^. Hence, 
by monitoring the increase of total Eq, E . ..P and E -I at 1+50 nm, or 
the decrease of E ...P at 550 nm, a measurement of kg could be obtained. 
The rate equation for this reaction is:
kobs = k2+k-l + k3 + k6[02  ^ (6)
The slope of a plot of &Q-^S vs [0g] gives kg -
To measure k^ , anthranilate, an equally strong competitive 
20inhibitor, was added in the second mixture, again preventing the RHR 
from occurring. In this case, however, the E -I complex is spectrally 
distinct from E . Since again the complex forms very fast compared to 
kg and k^ , a measure of the decay of the 1*50 nm absorption peak should 
measure the rate of decay of Eq ..,P. The value thus obtained for k^  
agreed well with that measured for <J>0\  the maximum turnover number 
for the enzyme. From these experiments Porter, Voet and Bright con­
cluded that:
10
(1) Loop B is the operative reaction path for neutral, amino 
acids; i.e., product is not released until after the flavin is reoxi­
dized.
(2) Product release, step 7, is the rate limiting step in 
this loop. This means that the oxidized substrate does not leave the 
enzyme active site immediately upon oxidation, but stays around long 
enough to aid in the reoxidation of the enzyme. Therefore inhibition 
involving a compound that becomes destructive upon oxidation is a possi­
bility.
5. The Nature of the Enzyme-Substrate Complex
Another long-standing problem which.Porter, Voet and Bright
addressed was the nature of the intermediate formed in the step.
+
It was felt that this step involved H abstraction with subsequent
substrate carbanion formation (for a review of this literature see
reference 15)* Previous attempts at measuring linear free energy
relationships led to confusing results because the differences between
binding rates (k-j_) an<i reaction rates (k^ ) could not be sorted out for
the various substrates used.'*"'* This difficulty arose because k  ^= 0
for most substrates so only the forward reaction could be monitored.
With phenylalanine, however, k  ^^ 0 and, again employing double
stopped flow experiments, k_^ could be measured directly. Using a
series of ring substituted phenylalanines to minimize the differences
in hydrophobic, steric and hydrogen bonding interactions, Porter, Voet
and Bright were able to measure the linear free energy relationships
of k = k They found that the magnitude of k 0 increased fairly rev —d -d
consistently with the increasing electron withdrawing power of the
11
substrate, in accord with the concept of a developing negative charge 
in the transition state of step 2S as would be expected if the H is 
abstracted as a proton in the step. Furthermore, the kinetic isotope 
effect was the same in both the k^ and the k  ^direction, indicating
at the enzyme active site during the two phases of step two. However, 
it is not clear whether it is removed by a basic residue of the apopro­
tein and later transferred to 11(5) of* the flavin, or is initially 
abstracted by the isoalloxazine ring. Abstraction by a basic residue
has generally been assumed. This would leave an anionic species to
21interact with the isoalloxazine ring. Mam, et. al. have shown that 
an anion is the active species in at least one case. They studied the 
interaction of FI with dimethyldihydrophthalates. Compounds I and
O X
III, which have a common carbanion were used:
that the H+ that has been removed from the substrate must remain bound
H
COOMeCOOMe
''COOMe
lOOMe
COOMe
V
Fl-II complex
The rate of formation of II from III is 1/10 that of the formation of 
II from I. This matches the relative rates of flavin complex formation 
by each species at high flavin concentrations where the reaction is
12
zero order in flavin. The reaction has been found to be base-catalyzed 
indicating that it is indeed the carbanion species that is reacting 
and not some common neutral isomer.
This concept of an anion as the active species is further 
supported by work on the unusual substrate NO^Et where the preformed
anion was found to be much more highly reactive than the neutral spe-
22 23 23cies. 5 NOgEt has been trapped as a covalent adduct at N(5).
Additional support comes from studies of the E ... P complex
which appears to be a charge-transfer complex between an anion and
flavin. Massey and others have amassed considerable evidence that
E^...P is a charge-transfer complex where the substrate is the electron
20 2U-^3donor and the flavin the electron acceptor. 9  ^ This explanation
of the long wavelength absorption of these species is supported by
3^  35molecular orbital calculations. 9 Bruice and his colleagues, however, 
continue to try to prove the existence of free radicals as the inter-
3 6-U6mediates in flavoenzyme oxidation reactions. The major supporting
evidence for these species being charge-transfer complexes rather than 
free radical systems is the lack of ESR spectra for these intermediates. 
However, the possibility of free radical, transient intermediates cannot 
be ruled out. These various experiments all support the concept that 
(a) the a-H is abstracted as a proton by a basic residue at the active 
site end that (b) it is the anion that interacts with the isoalloxazine 
ring.
6. The Form of the Product Released
For a long time it was felt that the enzyme released the
1*7altered substrate as the oxidized product. Yagi, et. al. were the
13
first to point out that an a-imino acid is released "by the enzyme which 
is then immediately hydrolized by the aqueous medium. Yagi measured 
an initial drop, then subsequent increase in pK as the oxidation 
reaction proceeded. The rise in pH was not observed, however, when 
proline was oxidized. He interpreted this data to mean that an imino- 
acid was being initially released for linear amino acids:
R R
E^T-C-H + CU :q +H- n^+I^'3 ,
COO
R
HN*=C +H20+
cooe
t 2 2i ecoo
pk = 6-7 drop in pH 
R
 5> NH ,®+Q=C
COO'
pk = 9.3 rise in pH
(8)
But for proline:
9
\
IJ^^COO0 + °2 'COO + h2°2+h
©
(9)
The imine is a stable species which is not hydrolyzed and therefore
the secondary rise in pH was not observed.
48Hafner and Wellner succeeded in trapping the mine being 
released using sodium borohydride. If an imine is released from the 
enzyme before it is fully oxidized, a racemic reduction product should 
be obtained (10b). Because the rate of reduction was 36 times the rate 
of normal hydrolysis (10a) this reduction product could be and was 
observed. They also found that the released imines can form Schiff
Ik
"bases -with amino groups of proteins and free lysine (10c) which can "be 
trapped "by sodium borohydride reduction,
©
DAAO f  HaBHjj f 2
R-C-COOH x ' ^ -C-COOH ----> R-C-COOH + R-C-COOH
I ; \ 36H * ^
NH2 0 / \  H H NH2 
J  (c j\ r nnmnoptically active \y w  Y 2 racemic
/ NK n \
.R-C-COOH l </ R /inv
\ OH ✓ R'-NH-C-NH0\  j | 2
/ \ COOH
o\y
R-C-COOH \, 3 R R
NaBH) ■N»_N=rC R » ^hh-C-
I ---- > I
COOH COOH
Coffey and coworkers had trapped just such a Schiff base
li9 50
when adding sodium borohydride to DAAO/amino acid mixtures. 5 Their 
work generated great excitement initially when it was thought that the 
adduct might represent the active site of the enzyme. But tests showed 
that the presence of these adducts had no effect on the enzyme’s 
activity and therefore they could not be at the active site.
Walsh et al.^ found a number of residues on DAAO capable 
of undergoing a similar reaction With D-propargylglycine oxidation 
products. In this case the enzyme’s activity was altered but not 
stopped.
52 .It now appears that this transamination side reaction
(10c) may be exploited by the oxidized substrate to aid hydrolysis.
When imino acids react with the a-amino group of glycine or other
15
amino acids, they become more susceptible to hydrolysis. Thus the amino 
acid substrate acts as a posative effector in its own oxidation. How­
ever, if the imine product reacts with the e-amino group of lysine or 
other primary amines as happened in Coffey’s and Walsh's experiments, 
it becomes more stable to hydrolysis, slowing the reaction. This reac­
tion has proven useful for trapping some DAAO oxidation products and 
showing that they are not suicide substrates since they leave the active 
site before undergoing this reduction.
7* Oxidation vs Dehydrogenation
Flavoprotein oxidases catalyze both oxidation and dehydro­
genation reactions. DAAO has been shown to be capable of catalyzing
both types of reactions,.depending upon the substrate used. For example, 
53Walsh et al.. found that when £-chloroalanine was mixed with DAAO 
anaerobically (in 100% nitrogen) pyruvate was formed exclusively. In 
100% oxygen only 3-chloropyruvate was formed. At intermediate gas 
mixtures combinations of the two oxidation products were formed. This 
is illustrated in eq. 11.
ci m 3+
chloropyruvat e +NH®
0
(11)
16
With a-amino-3-chlorobutyrate, only a-ketobutyrate was formed, regard­
less of whether or not oxygen was available. On the other hand,
two competing elimination reactions were observed. From experiments 
with a-amino-3-chloro[a- H]-butyrate it was concluded that DAAO reacts 
with the substrate to form an enzyme-bound enamine. This enamine is 
either (a) realeased into the medium where it spontaneously ketoniz-es, 
or, (b) protonated at the 3-position (with the former a- H) to form 
a-imino-butyric acid, as shown in eq. (12).
/
' e'fad h I FAD 
I /
R-CH-C-COO0 1 >> ( s-H^h
 ^ Cl NH0© R_C=r C-COO
m
©
el@v ,FAD
+  /
3 /
9 ©+ R-CH=C-C0o +i 2
' /FAD v  - .
{ e F 'V 0 1 ( R—C-C-COO '
\ ! 1 ff) /
V  H.FAD
ith3©
solvent
v
R-CH2-CfC02
‘ NH2©
• 11 n H NH£t)
z + r-c-ccoo0 r-ch^c-co20+
h 2° (12)
0
The relative rates of reactions (a) and (b) are temperature dependent, 
more elimination occurring at room temperature than at °^C. It is pos­
sible that a suicide substrate could exploit this elimination reaction 
to become active•
8. Competitive Inhibition
Much work has been done on the inhibition of DAAO, but most
19 20 55-57substrates turn out to be competitive inhibitors. ’ ’ However,
these studies provided some useful knowledge regarding subs.trat e-enzyme 
interaction. In particular, it appears that good competitive inhibi­
tors form charge-transfer complexes with DAAO in which the substrate
acts as an electron donor and the oxidized flavin acts as an electron
, 18,20,25,35acceptor.
This fact has been exploited in at least one case of irre­
versible inhibition, that of (-)EtN02 on DAAO as has already been 
23mentioned. Conversely, electron acceptors complex with the reduced
33 . 3^enzyme as expected from molecular orbital calculations.
In most cases studied so far (all but those of the RNOg series)
a -COOH group appears to be necessary for binding. The active site
also has a hydrophobic portion which can accommodate a short aliphatic
56chain (C^  molecules exhibit maximum binding) or a benzene ring.
Good competitive inhibitors usually have an unsaturated bond ct,0 to
the negatively charged group. Compounds with two anionic groups do
57not inhibit the enzyme.
9. Irreversible Inhibition 
Two irreversible inhibitors of DAAO have recently been
rQ Aq
found: Propargylglycine and N02Et(-)
a. Propargylglyc ine
The reactions of propargylglycine with DAAO have now been
xr Q
studied in some detail. Horiike et al. observed time-dependent in­
hibition of the enzyme, with covalent binding of an inhibitor species 
to the apoenzyme. This inactivation did not have first order kinetics, 
indicating that the altered propargylglycine must be released from
18
the enzyme before deactivating it in a second step. These observations
59were corroborated by Stock. Extending Horiikefs work one step fur­
ther, she was unable to find irreversible inhibition using whole liver 
and kidney homogenates. This experiment supports the idea that the 
propargylglycine product is being released before it can inhibit the 
enzyme. If the product remained in the enzyme’s vicinity until inacti­
vation, then one would expect the rate of inactivation to be nearly 
independent of other species present. If, however, the product spent 
some time in solution before inactivation, then it might react with a 
number of components in the system besides DAAO.
Marcotte and Walsh have studied the reactions of propargyl-- 
glycine in great detail.6^»51>6l pr0pargylglycine is an active substrate 
for DAAO with a =■ 0.6 mM and Vmax = T ymole/min»mg. Acetopyruvate 
was detected in large quantities and determined to be the final product 
of the oxidation process. No anaerobic turnover was observed with 
this substrate. (Anaerobic turnover is indicative of a,3-elimination, 
a process observed so far only with 3-chloro species.) A slow time- 
dependent, irreversible inactivation was also observed. The number 
of turnovers was found to be a function of the inhibitor concentration 
implying that the inhibitor or its precursor competes with substrate 
for enzyme. Inactivation occurred approximately once for every 2000 
turnovers. Acetopyruvate was shown not to be the inhibiting species, 
but the inhibitor was apparently released into solution before attack­
ing the enzyme since (l) the enzyme could be protected by addition 
of butylamine*hydrochloride to the system, (2) increasing enzyme con­
centration increased the rate of inactivation, and (3) the inactivation 
rate was not first order. Where radioactive inhibitor was used, 1.7
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labels per active site were added to the apoenzyme. Examination of 
the inhibited enzyme revealed not one, but a minimum of five distinct 
species of modified enzyme with changed activities and several totally 
inactive ones. Longer incubations with propargylglycine led to more 
different kinds of modified enzyme as determined by gel electrofocusing. 
Furthermore, modified DAAO showed a much decreased activity with D- 
alanine, but a greatlyv increased activity when the normally poor sub­
strate, D-phenylalanihe was used. D-Alanine is normally used to assay 
DAAO activity, and different laboratories have used different amounts 
of D-alanine in their assays. Because the measured activity of 
D-propargylglycine-modified-DAAO is a function of the concentration
of D-alanine used, the measured inactivation of DAAO by D-propargyl-
58 59 51glycine was not consistent from one laboratory to another. 5 ’ The
rate determining step of the catalytic reaction was also different in 
the modified enzyme. In native enzyme, product release is the slow 
step (see earlier discussion); in propargylglycine-modified-enzyme, 
the slow step became H+ cleavage from C^ . This and the changes in sub­
strate specificity indicate that the enzyme has been modified in such 
a way that the environment at the active site is greatly changed, but 
the active site itself is not blocked. This modification was found to 
be stable under all conditions tested.
With the modified enzyme thus characterized, Marcotte and
Walsh then undertook to analyze the sequence of reactions involved in
6lenzymatic oxidation of propargylglycine. In addition to the inacti­
vating species, two species capable of forming intense charge-transfer 
complexes with DAAO were observed. The first complex formed very
20
quickly with an absorption maximum at 580 nm. It was shown to be in 
rapid noncovalent equilibrium by the fact that added sodium benzoate 
bound preferentially to the enzyme at a rate of 0.08/sec, the dissoci­
ation rate of the enzyme-inhibitor complex. The initial maximum turn­
over number was greater than this rate of charge-transfer complex 
dissociation, so the charge-transfer complex must be forming from the 
oxidized enzyme. This charge-transfer complex decayed over 60-90 
minutes into a second charge-transfer complex which was less tightly 
bound. Native enzyme could not be recovered when protecting reagents 
are added to the first complex, but was recovered in preference to the 
second complex. This indicated that the first complex was formed while 
substrate was still at the active site, but the second was formed by 
reequilibration with a species from solution. Furthermore, this second 
complex could be formed using product generated in situ,which then had 
to migrate to the DAAO active site. (That is, previous reduction of 
DAAO itself was not required for formation of this charge-transfer 
complex.) This charge-transfer complex was not involved in covalent 
modification. No inactivation was observed during the lifetime of this 
charge-transfer complex. No inactivation was observed when this com- 
plexing species was generated in situ and allowed to migrate to DAAO 
*to form the charge-transfer complex. Therefore, the inactivating 
species must lie on the pathway between the first and second complexes. 
Marcotte and Walsh have devised Scheme I to fit their observations.
The allenic intermediate (8 of Scheme I) would be subject 
to nucleophylic attack whether by a basic residue on the amino acid 
to form an alkylated enzyme species, or internal, attack by the acid 
anion to form the lactone (6) in a 1,U Michael-type addition. This
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lactone was indeed observed and characterized by NMR. The availability 
of this ready internal attack is probably the reason why so many turn­
overs occur for each modified enzyme molecule formed. The fact that 
many different enzyme species were observed, shows that this alkyla- 
tion is not specific for any one amino acid residue. Propargylglycine 
is not a satisfactory inhibitor for the study of DAAO.
b. Nitroethane Anion
Nitroethane anion, in the presence of cyanide, rapidly and
23irreversibly inhibits DAAO. The absorption spectrum of the inhibited 
enzyme is characteristic of a flavin-substrate covalent adduct, with 
binding at N(5) of the isoalloxazine ring. When flavin is released from 
the apoenzyme by hot methanol, the adduct is found to remain with the 
flavin species. If water is added instead of cyanide, normal turnover 
is observed. Addition of any species with a free electron pair to the 
enzyme-substrate cpx.(see Scheme II) allows removal of the alkylated 
species and normal turnover. Cyanide does not have a free electron pair 
to donate to an elimination reaction and thus traps the species in an 
irreversible manner. Porter, Voet and Bright presented the equations 
of Scheme II to explain their results.
While NC>2Et(-) has proven useful for the study of DAAO in 
vitro, this strong anion cannot be supposed to be specific for DAAO 
in an in vivo system. Furthermore, cyanide, a substance well known 
to be lethal to living organisms, is required for inhibition. Therefore, 
this system is not useful for studying DAAO in vivo.
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C. The Chemistry of Flavin
Much fruitful knowledge has been gained from the studies of 
the inhibition of DAAO and other flavoenzymes. Another, equally fruit­
ful area of investigation has been research into the nature of the 
flavin moiety of the enzyme system. It is known that the flavin portion 
of the enzyme is intimately involved in the catalytic process. Attempts 
have therefore been made to produce similar reactions in the simpler 
noncatalytic free flavin system, then deduce what must be happening at 
the enzyme active site.
The following questions can be asked about the flavin-substrate
system:
(1) What geometric and electronic changes does the flavin undergo 
during its reduction and reoxidation phases?
(2) What is the nature of the flavin-substrate interaction?
(3) What portion of the flavin molecule is involved in substrate 
interaction and flavin reoxidation?
1. The Geometry of Flavin
Oxidized flavin (FI ) is a* planar structure with complete 
delocalization of its electrons (Fig. Ua). Fully reduced flavin (FI Hg) 
has a butterfly configuration with each of the two side rings bending 
out of the plane (Fig. Uc). In a planar structure, the central ring 
of the fully reduced flavin would have 8tt electrons, an unstable situ­
ation (Fig. Ub). In the enzyme environment, these changes in conforma­
tion may well be restricted. It is thought that such restructions may 
be responsible for the relative reactivities of different flavoenzymes
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with 0^ . (For example, dehydrogenases will not react with 0  ^to 
reoxidize while oxidases react extremely quickly.)
Bruice has attempted to explain susceptibility toward 0^  
attack in two contradictory ways. ,J First he notes the potential 
antiaromaticity of the central pyrazine ring of a planar reduced flavin 
(Fig. Vb). The two extra electrons in the planar form would occupy 
antibonding orbitals "to provide diradical character". This would allow 
direct covalent bonding by molecules having triplet states such as 
ground state 0 . Conversely, he considered the case of the fully bent 
system. Here the orbitals of the free electron pairs tend to interact 
(Fig. Uc). This interaction will be greater when both orbitals are equa­
torial as when both N(lO') and N(5) alkylated (presumably the case 
in the DAAO system where E .,.P remains intact until after 0^  attack).
The result of this interaction is a splitting of the orbital energies 
so that one is higher than the other allowing for easy and stable radical 
formation. This radical species might exist as a transient intermediate
activated toward attack by the triplet 0^ ground state.
These theories support exactly opposite conformational 
tendencies as the source of activation toward 0^ attack, leaving the
student of these systems in a quandry. Presumably those enzymes not
able to react with 0g would have a geometry somewhere in the mid-range
between these two extremes.
62Tauscher et al. synthesized a series of N(5) substituted 
reduced flavins and measured the angle between the two butterfly wing 
planes. They found a variation of from 9-35*5°. They measured the 
conformational energy of these structures and found it sufficiently
large to effectively "freeze" specific configurations providing an
effectively chiral N for H transfer. Unfortunately they did not measure
the susceptibility of any of these compounds for 0^ attack, so we are
not any the wiser on this controversy. Flavin can also be found in
the half-reduced free radical semiquinone state. The different forms
flavin is able to take and the absorption maxima for each of these
kkforms are shown in Fig. 2.
2. The Flavin-Substrate Interaction
Because flavin is the major chromophore of a flavoenzyme 
system in the visible region, one can learn about the changes occurring 
in this coenzyme during catalytic turnover by spectrophotometric monitor­
ing of the reaction (c.f. Fig. 3). The observed changes in the spectrum 
can then be compared with those occurring in well characterized simpler 
flavin systems. In this way, researchers have been able to learn about 
apoenzyme-coenzyme binding, when, furing turnover, the flavin is in
its oxidized and reduced states, and something of the nature of the
63 61enzyme-substrate complex. Beinert 9 was the first to exploit the
spectral properties of flavin in this way.
Spectral monitoring of the anaerobic catalytic reaction of
DAAO with normal substrate shows an initial single exponential increase
in -A-e^ q for the RHR). This corresponds to the increase in
.•. P, an apparent charge-transfer complex between flavin in its
2h 25 27reduced form and substrate ’ *• (see Fig. 3). This A*.-,, peak then55V
decays exponentially (k^  of equation 2). k^ is independent of [S].^
Covalent intermediates have been postulated and, in some cases,
23 65 69trapped. 5 Thus, it appears that variation between a
25
charge-transfer complex transient intermediate and a transient covalent
intermediate may he a function of the specific enzyme-substrate system.
All available sites of the flavin ring have at one time or
another been postulated as the actual participating active site in
3)4 35
substrate oxidation. Molecular orbital calculations ’ have shown 
that the N(5) and C(i+a) positions of the oxidized flavin are most sus­
ceptible to nucleophulic attack. In the reduced flavin molecule, these 
are the sites most susceptible to electrophylic attack. The N(5) posi­
tion should be the most prone to attack in either case.
The molecular orbital calculations are supported by the. 
experimental facts. Charge-transfer complexes seem to form most readily
with electron donating species reacting with oxidized flavin or electron
2k 33deficient species reacting with reduced flavin. * The only covalent
species isolated to date from an enzyme system are bound either at N(5)
3Tor C(ka). Williams and Bruice claim covalent bond formation is a 
spurious reaction and true oxidation of substrate occurs via radical 
intermediates. Nonetheless, it seems highly likely that these atoms 
are involved with the catalytic activity of the enzyme and design of 
inhibitors of flavin concentrate on exploiting reactions at these 
centers.
In the case of DAAO, it is known that the a-H is removed in 
conjunction with purple complex (E^ .-.P) formation. The resulting
substrate carbanion is apparently being stabilized by interacting with
/ \ . 36the flavin ring at N(5). This could occur in either of two ways.
3
Planar overlap of the filled carbanion orbital lobe (sp ) with the 
frontier orbital at N(5) should be prevented by the presence of a
non-bonding electron pair at N(5) (Fig. 5a). However, out-of-plane 
overlap between the filled carbanion orbital and the flavin anti­
bonding molecular orbital can occur (Fig. 5b). Strong absorption is 
predicted in the long wavelength charge-transfer band for a planar 
complex, but only weak absorption is predicted for an out-of-plane com­
plex. Weak absorptions are observed without exception for these com­
plexes with DAAO.
3. Deazaflavin
Having decided that W(5) of the isoalloxazine ring was an
important position for catalytic activity in flavoenzymes, the next
step was to synthesize a flavin modified in this position so its impor-
70tance could be tested. O'Brien, et al. succeeded in synthesizing 
798~dimethyl-5-deazaribo flavin (dFl). which can convert to the reduced 
1,5-dihydrodeaz aflavin (dFlrH2):
 ^+2e Me
+2Ht '
Me
Me Me'm
dFl dFlrH2
This modified flavin has been very valuable in clarifying some points 
of the normal flavin redox reaction.
Deazaflavin has so far been substituted into more than thir­
teen enzyme systems and has been shown to oxidize the same substrates
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as normal enzymes, though at a somewhat slower rate. Deazaflavin. has., 
enhanced reactivity toward oxidized substrate (the reverse of k^ , equa­
tion 2), a reaction available to normal enzyme only under anaerobic
conditions and with excess oxidized substrate and ammonia, or with
Tl 172 3.3certain unfavorable substrates (e.g., phenylalanine). * *
Deazaflavin has about the same binding affinity to apoenzymes
as flavin. Absorption, fluorescence and circular dichroism spectra are
quite similar. Therefore, deazaflavin is probably binding at the same
71portion of the apoenzyme as normal flavin does. Apoenzyme still pro­
vides its function of enhancing the catalytic reaction rate. The rate
limiting step in oxidation (RHR) is the same for both types of flavin.
72*These compounds are also complexed by electron donors. Molecular
orbital calculations show the C(5) position to be most prone to 
3^  35attack. 5 Free radical species are considerably more difficult to 
71generate. This is to be expected since the fully reduced state no 
longer has an unstable 8 t t  electron central ring and is not capable of 
the lone pair-lone pair orbital interactions available to reduced flavin 
that enchance the probability of radical formation. (See above dis­
cussion of the properties of reduced flavin and Fig. U.) This may 
account for the relative unreactivity of dFl^H^ towards 0^ (triplet 0  ^
■would be more reactive toward a transient free radical or excited state 
species than toward the ground state reduced deazaflavin molecule).
Enzyme catalized transfer of substrate hydrogen to flavin 
has been difficult to demonstrate due to the rapid exchange rates of 
reduced flavins. Modifying the enzyme by replacing flavin with deaza­
flavin slows this reaction and prevents reoxidation via 0^  so that the
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H transfer step (RHR) can be studied in detail. Furthermore, dFl H0r d
now has a chiral center at the proposed active site so the stereochemistry
of this H transfer can also be studied.
Using N-methylglutamine synthetase, -Jorns and Hersch were
able to show that the modified enzyme underwent the same 2-step cataly-
73 7^tic reaction as native enzyme: ’
E-dfMN + L-glutamate >>E^giutaryl + NH3 (a)
(1U)
E ^ dFMRHg + met w 2_amine-^ E-dFMN + N-methyl-L-glutamate 
^glutaryl
(b)
at 1-5$ the normal rate. Using [a- H] glutamate, they were able to
3
show approximately a 1:1 relationship between H incorporated into the 
enzyme and the amount of produced. When the enzyme was
3
separated into the three components, the H was found to be associated
with the dEMNHg moiety. If the enzyme was treated with methylamine
3
before analysis, the H was then incorporated into N-methylglutamate.
The fact that there were 2 protons, one labeled and one not, at C(5)9
yet only the labeled one was incorporated into N-methylglutamate
3
indicated the stereoselectivity of the reaction. This H was not
exchangeable with solvent and therefore remained at a protected site
on the enzyme during both steps of this reaction, probably at C(5) of
the deazaflavin.
To confirm the stereospecificity of hydrogen transfer to
75deazaflavin, and to transfer to C(5), Spencer, et al. , compared the
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kinetic isotope effect on oxidation of dFl Eg reduced (a) by borodeute-
ride, and (b) by oxoreductase + U-R=[ HjNADH and monitored the changes
by NMR. Borohydride presumably reduces randomly at either face of
deazaflavin whereas the enzyme system should reduce stereospecifically
on only one face of the deazaflavin molecule. Oxidation of system (a)
gave complicated kinetibs and NMR studies showed an absence of almost
all of the C(5) proton absorption consistent with the expectation that
most of the deazaflavin would still be deuterated at C(5)* When the
enzyme reduced species (system (b)) was reoxidized by riboflavin, the
2 +kinetic isotope effect was 3.0, reflecting chiral H addition and sub­
sequent abstraction. Further support for a chiral hydrogen transfer was 
obtained from studies with NAD:flavin oxidoreductase which reduces 
substrate 5-deazariboflavin. Preparation of [U-R- H]NADH and incubation 
with oxidoreductase and riboflavin indicated stereospecific transfer of 
this H by complete volatilization (>90%) of the counts with, a kinetic 
isotope effect of U.8. With deazariboflavin, a kinetic isotope effect 
of 3.3, for [U-R- H]NADH was observed. The bs isomer showed no kinetic 
isotope effect. There was a large difference in the rate of H transfer 
between flavin and deazaflavin, but this step was rate determining in
T  '7T
the RHR in each case. Jorns and Hersch * , using glucose oxidase and
DAAO + [a- H]-substrate also demonstrated stereospecific H transfer to 
and from deazaflavin.
Deazaflavin has indeed proved a useful model for clarifying 
the flavoenzyme oxidase system. It always binds at the active site.
It is capable of oxidizing normal substrates, and undergoes the reverse 
of this reaction very readily. Its sluggish oxidation by 0^  indicates
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that the N(5) unbonded electron pair is essential for rapid oxidation 
by 0^ * It has helped confirm that a-H is transferred to C(5) (N(5) of 
the normal flavin system). This transfer may be either directly to C(5) 
or via an enzyme basic residue in a stereospecific manner. The fact 
that nonenzymatic transfer between substrate and deazaflavin has been 
observed argues for the direct transfer of this hydrogen to C(5)» but 
the formation of charge transfer complexes during the hydrogen abstrac­
tion step of many flavoenzymes makes assistence from an enzyme basic 
residue more plausible. In any case, work on deazaflavin has conclusively 
shown that N(?) is intimately involved at the enzyme active site in 
flavoprotein oxidases.
Do Suicide Inhibition
How can we exploit the knowledge gained about the nature of 
the active site of DAAO and the reactions it catalizes, in order to 
design a suicide inhibitor of this enzyme? First, we need to find a 
compound sufficiently like normal substrate that it can bind at the 
active site. A modified D-amino acid seems most acceptable. Second, 
we want it to be unreactive until it has been modified by the enzyme. 
a-H abstraction appears to be the most likely step in catalysis to be 
exploitable for this purpose. Third, the modified compound must now be 
sufficiently reactive to bind at the active site before it dissociates 
from the enzyme. The generated active species might be an electrophile 
which could attack the proposed base present for initial abstraction 
of the a-K. However, if the species is not reactive until after the 
proton is removed, this base may no longer be available for attack. 
Alternatively, the active species could be a nucleophile, designed to
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attack the electron deficient isoalloxazine ring of the flavin coenzyme. 
NO^EtC-) is an example of a compound sufficiently reactive to fom a 
covalent hond and not just a reversible charge-transfer complex with 
flavin. However, as mentioned above, this compound lacks suicide sub­
strate properties and is not suitable for in_ vivo work.
What kind of suicide substrates for enzymes have been prepared 
so far and how do they work?
1. 3-Decynoyl-N-AcetyIcysteamine
Konrad Bloch was the first to prepare and characterize a
r j Q  7 C s
suicide substrate. 9 He was studying the biosynthetic formation of 
fatty acids and found that 3-decynoyl-N-acetylcysteamine (3-decynoyl-NAC) 
an acetylenic analog of a normal 8-hydroxy-decanoyl thioester dehydrase 
substrate was a potent and highly specific inhibitor of the enzyme. The 
inhibition was substrate protected, but completely irreversible. The 
optimal chain length for the inhibitor coincided with that for optimal 
substrate, indicating that binding was at the active site and that it 
occurred in the same manner as for normal substrate. Furthermore, only 
the N-acetyl cystamine form of the substrate was active, indicating
high specificity of this substrate for the target enzyme.
80Further studies clarified the mode of inaction of this 
inhibitor. In these experiments both 3-decynoyl-NAC and 2,3-decadienoyl- 
NAC were tested. The allenic inhibitor was even more effective than 
the acetylenic one. Inhibition by it was not affected by [S]. The 
enzyme was known to catalize the transformation of cis-3-decenoyl-NAC 
to trans-2-decynoyl-NAC. An analogous enzymatic isomerization of the 
acetylenic thioester would produce the allenic NAC derivative. A
kinetic isotope effect was found with inhibition by the acetylenic sub­
strates but not with allene inhibition. Free 2,3-decadienoic acid also 
inhibited the enzyme. Thus., a-H must be removed from the acetylenic 
compound in a rate limiting step to generate the active allene species. 
This data supports equation 15 as being the mode of inhibition of 
6-bydroxydecanoyl thioester dehydrase.
0
/ \ IICH3(C H p ) 5-C E C -C H 2 -CHAC
/
s _l o w ,  enz. catalysis
ch3(ch2 )5-ch=c=ch-cnac
^ /N-.. (15)
N J 1N ^CHp-enz. 
fast H
V
0
I
CH3 ( CH2 ) 5CH2-e=CHCNAC-
^^CHg-cnz .
3ZLpH studies indicated that the active species was the neutral allene, 
not the anion.
82Model inhibition studies on histidine interaction with allenes 
indicated that one of the imidazole nitrogens of histidine can serve as 
nucleophile, attacking the central carbon of the allene in a l,U-Michael 
type addition reaction:
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HC=C=CH-C-X
0
HC=C-CH=C-X
^ / ^ C H 2enz
%
H
O'
'CH^ enz
H (16)
The 3^-dienoate has no inhibitory effect on the enzyme. Thus the 
reactivity of the allene must either he enhanced hy the adjacent conju­
gated carbonyl or must be severely restricted by stereochemical conjunc­
tion of the allene and the histidine at the enzyme active site, or both.
This new tool in enzyme inhibition has been exploited by a
83 86number of. workers, most notably in steroid biosynthesis. ~
2. Other Acetylenic Inhibitors 
Similarly, propargylglycine was found to inhibit y-cystathio-
Q r r
nase, presumably by a-H abstraction, rearrangement to an allene and
nucleophylic attack by a base at the active site. The reaction was
never fully characterized.
Monoamine oxidase (MAO) has also been inhibited by an acetylenic
substrate, but is inhibited 25 times more slowly with the comparable
88allenic substrate, in vitro. In vivo these two species exhibited
approximately equal potency. Perhaps the two substrates were converted 
in vivo into some common intermediate before reaching the enzyme’s ac­
tive site.
89In a more detailed study Abeles and coworkers followed the 
inactivation of MAO with 3^dimethylamino-l-propyne. Proteolytic
3b
digestion of the inhibited enzyme yielded a flavin peptide containing 
one mole of inhibitor per mole of flavin. Where chemical and spectral 
properties were compared with model compounds, they were found to 
resemble those of an N(5) adduct containing the structure -N-CH=CH-CH=N+'. 
This inhibition must therefore be different than that occurring with 
8-hydroxydecanoyl thioester. Using the knowledge compiled by Bruice
kbon flavin reaction mechanism , they postulated three possible reaction 
mechanisms for adduct formation: carbanion formation, radical formation,
and complete oxidation.
If the enzyme catalizes a-H abstraction, the intermediate 
carbanion could add to N(5) of oxidized flavin yielding the observed
adduct after protonation:
© (IT)
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That is,, oxidized flavin reacts with reduced inactivator to form a. 
stable covalent bond. This attack is in line with what we know about 
N(5) being electron deficient and susceptible to nucleophilic attack 
by substrate. But there is no activating group adjacent to the site of 
proton removal, so the likelihood of a carbanion intermediate is 
questionable.
radical pair intermediate complex involving flavin and substrate. This 
complex could be formed either by H? transfer to flavin or from electron 
transfer from carbanion intermediate to flavin. Collapse of the complex 
plus adduct protonation would give the observed species.
In this case partially reduced flavin and partially oxidized substrate
interact. As noted above, such intermediates cannot be detected in
many flavoenzyme systems.
Complete oxidation of inhibitor gives + HCSCC^NCCH^Jg
which is highly reactive and should be an excellent receptor in Michael
addition reactions. Addition of N(5) across the triple bond would give
the observed adduct. As mentioned in an earlier section, FI is in-» r 2
deed nucleophylic.
*2 ^
Bruice has suggested the possibility of the formation of a
V
adduct (18)
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One should note that the usual oxidation catalized by MAO 
is at C(l) of the substrate amine. In the observed adduct, attachment 
is at C(3). Thus, either N(5) is not the immediate site of normal 
oxidation in this enzyme, or an abnormal oxidation is taking place with 
this inhibitor.
3. 3-Nitropropionate
Another interesting suicide inhibition is that of 3-nitro-
90propionate on succinate dehydrogenase in rate liver mitochondria. 
Succinate dehydrogenase catalizes the transformation of succinate into 
fumarate in the Krebs Cycle. Bright modeled this study on his success­
ful inhibition of DAAO by nitroethane anion and looked at the isoelec- 
tronic nitro compound of succinate:
0 0 0 0
'N Q/f N\  /'
©  ! C~CH2CH C-CH -CH -C ©
»/  ^  ^ \ !/ * * \\
0 0 0 0
3-nitropropionate succinate
Furthermore, he reasoned that since succinate dehydrogenase oxidizes 
the 2,3 position of the physiological substrate and not just one carbon 
as DAAO does, that the system could be inactivated by collapse of the 
XJ(.5) adduct expected to be formed in analogy with the NO^Et ©  /DAAO 
reaction (compare with Scheme II).
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-> ©00C-H2C-r:-wn
V (19)
i
H “H
inactive enamine adduct
That is, there should he a second internal base available to catalize 
this secondary H+ abstraction as it would in normal dehydrogenase 
act ivity.
tion was found, which was a function of [I] and [S]. The inactivated 
enzyme could not be revived by normal methods. No external nucleophile 
was required for inhibition. Respiratory rates, respiratory control 
rates and ADP/O ratios were unaffected by the concentration of the 
inhibitor, indicating that only the Krebs Cycle is stopped. All these 
data indicate that 3-nitropropionate is indeed a. highly specific, 
time-dependent suicide substrate of succinate dehydrogenase.
When this compound was tested, a first order rate of inhibi-
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H« 2-Kydroxy-3-Butynoate
Perhaps the work most relevant to the search for a suicide 
substrate for DAAO has been that done with the acetylenic substrate,
2-hydroxy-3-butynoic acid. It has been found to be a suicide substrate
91-93 9*+for lactate oxidase, D-lactate dehydrogenase, L-lactate dehydro-
95 9 6genase, and glycollate oxidase. In every case covalent adduct
formation occurs between inhibitor and flavin. None of these enzymes
form irreversible covalent adducts with 2-hydroxy-3-butenoate or 3-butynoic
acid. That is, both the hydroxy and the acetylene functional groups
appear to be necessary for inactivation.
a. Lactate Oxidase
The reaction with L-lactate oxidase (L-LO) from Mycobacterium
smegmatis has been most thoroughly studied. 2-Hydroxy-3-butynoate
reacts with the FMN coenzyme (see Fig. l) of L-lactate oxidase to form
91a fluorescent species stable to autooxidation. Using 2-hydroxy-
3 33-t^- H]-butynoate and 2-hydroxy-3-[2- H]-butynoate, it was established
that the a-H was lost, but the y-H remained in the adduct although no
longer attached to an acetylene group. Apoenzyme could be reactivated
by exogenous FAD indicating that there were no detrimental reactions
of inhibitor with the apoenzyme. The inhibitor was found to partition
93between catalytic oxidation and inactivation. The amount of oxidation 
was a function of the oxygen concentration, but independent of the con­
centration of the inhibitor. Under anaerobic conditions, enzyme and 
inhibitor interacted on a 1:1 basis (assuming only the L-hydroxy acid 
isomer reacts with L-lactate oxidase) to form the inactivated species.
These data indicate that both reactions occur from a common intermediate.
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This intermediate was considered to be the transient charge-transfer
complex (X = 600 nm) observed under rapid reaction techniques. The rasLX
charge-transfer complex was assigned to an interaction between reduced
enzyme and oxidized inhibitor: EF1 Hg...2-keto-3-butynoate. This species
did not fluoresce. Known complexes of a-ketoacids with reduced flavins
97exhibit similar spectral and fluorescent characteristics. This com­
plex was not stable and converted to an inactive species with X =max
318, 368 which was strongly fluorescent. This modified flavin was
unstable and slowly (over 2k hours) converted into another, this time
stable species. Absorption spectra and fluorescence characteristics
of the initial adduct resembled those of C(^a)-N(5) bridged FMN deriva- 
97tives. In order to test the hypothesis that it is the a-ketoacid that
is the actual inhibiting species, this highly unstable compound was
generated in situ from 2-hydroxy-3-butynoate using lactate dehydrogenase 
= 93and NAD . Reduced enzyme was generated photochemically in a nitrogen 
atmosphere in order to avoid complications arising from slow formation 
of oxidized enzyme by reversal of the equation:
EF1 + L-lactate^EF1 -L-lactate  -ox ox ^
EFl^H^ • pyruvat e EFl^H^ + pyruvate (20)
Other conventional methods of generating reduced enzyme could not be 
used as they would also reduce any ketoacid being formed. In this 
reaction a slow but measurable inhibition was indeed observed. The 
slowness of this reaction was probably due to the slow rate of associa­
tion of a-ketoacid with reduced enzyme at such low oxidized substrate
levels. (The reverse.HER is normally run in a large, excess of oxidized
substrate and is still slow.) Thus, it was shown that the a-ketoacid
can react with reduced enzyme and inactivate it.
The next step was to determine the structure of the initial
and final covalent adducts. Model flavins were synthesized and their
characteristics compared to those of the modified L-LO species. When
C(4a),N(5) -propanodihydro-FMN:
/(CH20H)3-CH20P03=
un,
Me
was prepared and its absorption spectra and fluorescence measured, they 
were found to be very similar to those of the initial adduct. When 
this initial adduct was reacted with sodium borohydride, it exhibited 
new spectral and fluorescence characteristics. These changes could 
only be matched when model flavin-N(5)-C(4a) adducts were reduced with 
borohydride. The structure of the product obtained from 4a,5-dihydro- 
4a,5-propano-3-methyl lumiflavin reduction was found by ITMR and 
elemental analysis to be:
Me
Me
kl
98Hemmerich and coworkers have synthesized compound A and found its 
spectral properties to be similar to those of the initial adduct. It 
is unstable in water and undergoes the following decomposition:
Me MeMe
Me
— >
1 Me*
— >
Me
A B C
These reactions are consistent with the observed instability of the
initial adduct formed on inactivation of L-lactate oxidase by 2-hydroxy-
3-butynoic acid. Furthermore, the final adduct, when released from
the holoenzyme with hot methanol and purified, exhibited an absorption
li*spectrum very similar to that of compound C above. Studies of C 
labeled adduct established that the carboxyl group of the hydroxy acid 
and Cg of the flavin remained bound in the initial adduct, but that the 
flavin Cg was lost on formation of the final adduct. Equation 21 was 
proposed for the sequence of reactions occurring during isolation of 
the borohydride stabilized adduct.
OOCCHC=CH
I
OH
OH
o MeOH<-
apoprotein 
precipitate
Stable Adduct Released 
from Enzyme
Enzyme Bound Inactivator 
Adduct
OH
Enxyme Bound Reduced 
Adduct
(21)
other products
.0
Several mechanisms can be envisioned for the formation of the flavin-
inhibitor adduct. It is unlikely that, as in the case of B-hydroxy-
79decanoyl thioester attack is from an allenic intermediate. An allene 
would be expected to undergo nucleophylic attack at the central allene 
carbon, not at and C^ , the observed attachment sites. However, an 
allene anion could•initiate attack at C^a of flavin, leading to the 
observed adduct:
k3
R
Me
mMe'
0
OOC-C-C=CH
I
OH
R
Me
Me
OOC-C-'
1
0
R
^OC J ^ /  0
OH
R
Me
Me
0
OOC-C=C=CH
I
OH
V
R
Me
Me
e /
OOCk^
I
OH
Alternatively, attack could "be “by the keto acid on reduced flavin. 
A possible mechanism for this reaction might be:
kk
R R 0
Me.
Me
0
Me,
OOC-C-C=CH
0
OH 0
CH 0
OOC-C-CH
Me
intake of 
solvent proton 
as indicated 
by 3H20 
experiments
\y R
Me'
Me
00C
OH
CH 0
e  //
iic
OOC-C
The two mechanisms are difficult to distinguish kinetically since 
E ...S and Er..,P are in equilibrium. But the analogous vinylglocollate, 
which should be equally prone to the Michael type addition of equation 
(23) does not inhibit any of the enzymes inhibited by ot-hydroxy- 
butynoic acid.
5^The significant result of these experiments is that the a-C 
binds to N(5) and therefore is presumably located next to it during 
normal oxidation. This adds to the growing evidence that N(5) of the 
isoalloxazine ring is the center on the flavin coenzyme involved in 
substrate oxidation.
Related experiments done in MassyTs laboratory on D-lactate
99oxidase indicate that inhibition by 2-hydrcxy-3-butynoate results in 
an N(5)-C(6) bridged adduct with the a-C again attached to N(5)* If 
this is indeed the case, then this enzyme must be holding the D-a-hydroxy 
acid in the same stereospecific orientation vis a vis the flavin N(5) 
as the L-a-hydroxy acid is held by L-lactate oxidase.
Regardless of the mechanism of inactivation, these studies 
provide valuable insight into the position and orientation of the sub­
strate at the active site. Both D- and L-lactate oxidase form adducts 
with a-hydroxybutynoic acid which have the a-C attached to W(,5). This 
confirms the theory that N(5) of the isoalloxazine ring is intimately 
involved at the active site in substrate oxidation in at least some of 
the flavooxidases. Furthermore the fact that the L-2-hydroxybutynoic 
acid is bound to the flavin L-lactate oxidase at C(Ua) whereas D-2- 
hydroxybutynoic acid is bound to the flavin of D-lactate oxidase 
at C(6) implies that the flavin may require a specific orientation of 
the a-C of the substrate for oxidation. Thus it appears that N(.5) is 
indeed the crucial center on the flavin nucleus for oxidation and that
the enzyme orients the substrate so that the stereochemistry of this
©
active site interaction (a-C...N(5)) is fixed.
6^b. Other Enzymes
G-lycollate oxidase from pea leaves has also been inhibited
96by 2-0H-3-butynoate in its sodium salt and methyl ester forms. This 
enzyme normally oxidizes glycollic acid, but any straight chain L-2- 
hydroxy acid up to and including L-2-hydroxy caproate is easily 
oxidized by the enzyme. In in vitro studies, a substrate dependent 
inactivation occurred, but it was not first order. As with DAAO inhibi­
tion by propargylglyeine which was also not first order in vitro, no 
time-dependent irreversible inhibition was observed in vivo. However, 
competitive inhibition was observed and the methyl ester was a more 
effective competitive inhibitor than the sodium salt.
A series of acetylenic substrates, RC=CCH(OH)COOH, where 
R=H-, Me-, Et-, Pr- and Bu- were tested with LAAO and found to be active 
substrates Where R=H, inactivation occurred after about 25 turn­
overs, only the flavin and no amino acid residues were modified. All 
other substrates exhibited much poorer inhibition qualities. Perhaps 
the C^-H is involved somehow in the inactivation process. More likely, 
groups larger than -H provide steric hindrance to the proper orientation 
for inhibition (both equations 22 and 23 postulate initial attack on 
the flavin by of the inhibitor which may be prevented where a bulky 
side group is attached to this carbon).
D- and L- lactate dehydrogenase (LDH-) have also been inhibited
9b 95by 2-hydroxy-butynoic acid. 5 These enzymes catalize the removal of
2- and 3- hydrogens rather than oxidation of Cg.
D-lactate dehydrogenase and D-lactate dehydrogenase-coupled 
transport in E. coli membrane vessicles were both specifically inhibited
7^9Uby the acetylenic suostrate, D-lactose protected the enzyme against 
inhibition. Neither 3~butynoate nor 2-hydroxy-3-butenoate had any in­
hibitory affect of enzyme activity. The enzyme underwent an average of 
35 turnovers with inhibitor before being rendered inactive. All these 
facts imply that the inhibitor must have substrate properties and must 
be altered by the enzyme’s natural reactions into an active inhibitor 
species. This is supported by inhibition specificity studies. In vitro, 
both D-lactose and succinate-NADH oxidation were monitored. Only the 
D-lactose oxidation was affected. In vivo, D-lactate dehydrogenase- 
coupled lactose, prolene and valinomycin-induced rhubidium transport 
were compared with ascorbate-phenzaine methosulfate-dependent transport 
and a-glycerol-P-dependent threonine transport. Only the D-lactate 
dehydrogenase dependent transport was inhibited. Thus, the inhibitor 
appears to be quite specific for the.target enzyme.
As in the lactate oxidase case, adduct was found between the 
inhibitor and the flavin coenzyme. Addition of fresh FMN to apoenzyme 
separated from the inhibited holoenzyme reconstituted active enzyme.
In an interesting aside, the authors noted that the lactate dehydrogenase 
from rabbit heart muscle, which uses pyridine nucleotide rather than 
FMN as a coenzyme, was not affected by 2-hydroxy-3-butynoic acid. This 
inhibitor appears to be specific for the flavin nucleus.
Using L-lactate dehydrogenase (cytochrome bg) from Baker’s 
95Yeast, Lederer also observed inhibition by 2-hydroxy-3-butynoate in 
a first order process. Spectra of the inhibited species are similar to 
those for D-lactate dehydrogenase and lactate oxidase reported by 
Walsh.91,9^
hb
In this series of studies, both oxidases and dehydrogenases 
which use flavin as coenzyme were inhibited in a suicidal manner and 
always only on the flavin portion of the holoenzyme. By comparison of 
spectra, the adduct species appears to be the same in each case. Thus 
this inhibitor appears to be general for a broad class of flavoproteins.
2-Hydroxy-3-butynoate was also tested as a inhibitor for
99DAAO but the kinetics were complicated and the reaction was never 
characterized.
5. Justification of the Choice of Inhibitors for DAAO
When choosing the most likely set of suicide inhibitors for 
DAAO, a major consideration was the similarity between lactate oxidase 
(which catalizes the transformation of a-hydroxy acids to cx-keto acids) 
and DAAO (which catalizes the transformation of a-amino acids to 
a-imino acids). The catalized reactions are very similar as is the 
substrate size. Both abstract a proton so that the substrate anion can 
interact, with flavin. Both appear to orient the sxibstrate so that the 
a-C anion is adjacent to N(5) of the flavin.
The inhibitor species for DAAO most analogous to 2-hydroxy-
3-butynoate for lactate oxidase is 2-amino-3-butynoate, The C^  compound 
should be more reactive than any longer chain, as indicated by the stu- 
dies of Dixon and Kleppe on maximum chain length, and those of Cromartie 
and Walsh using LAACf^^ showing protection from inhibition when groups 
larger than -H were attached to the far side of the acetylene. If the 
acetylene is removed farther from the a-C, other reactions than the 
2-hydroxy-3^butynoic acid inhibition appear to take place as indicated
1*9
by the complicated propargylglycine story* Other a-substituted butynoic 
acids whose a-H can be abstracted by the enzyme should also exhibit 
inhibitory properties. Therefore, we proposed to synthesize some 
2-substituted-3-butynoic acids to test for suicide inhibition properties 
on DAAO.
II. MATERIALS AND METHODS
All reagents were analytical grade unless otherwise stated. 
Solvents were evaporated on a Buchi-Rotavapor-R. Infrared spectra 
were recorded on either a Bausch and Lomb Spectronic 250 or a Perkin- 
Elmer 337 Spectrophotometer. Gas Chromatographs were run on a Hewlett- 
Packard Research Chromatograph, Model 5750 using a 6 foot column of 
15# carbowax, 20M on chromosorb AW-DCMS. High pressure liquid chroma­
tography (HPLC) was performed on a Waters Associates High Pressure 
Liquid Chromatograph, Model 241+ using either an Analytical yBondapak 
C^g column with a 10y silica particle size or a Preparative Porasil C^ g 
column with silica particle size 37-75. NMR- spectra were obtained on a 
Hitachi Perkin-Elmer R-20B High Resolution NMR Spectrometer. pH adjust­
ments were made using a Fisher Accumet pH Meter, Model 230A, equipped 
with a glass body combination e-5A electrode. A Precision Scientific 
Company Model 25 Shaker Bath was used to incubate all enzyme solutions. 
The absorbance at 525 nm was measured on a Beckman Acta MCI Spectro­
photometer .
A. Synthesis of n-Dibutyltartrate
1.75 g 4-methyl-benzene-sulfonic acid monohydrate were rinsed 
into a 1 liter 3-necked flask with 600 ml benzene. The flask was 
equipped with a Dean-Stark trap and a reflux condenser. The mixture 
was dried by refluxing 1-1/2 hours. Then 150 g tartaric acid and
50
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276 ml n-butanol were added and the mixture was allowed to reflux 
2k hours. Water was removed from the trap periodically.
The reaction mixture was transferred to a 2 liter separatory 
funnel and washed with 3x200 ml portions of water, then 3x165 ml portions 
of 2,5$ sodium hydroxide, dried over magnesium sulfate, and filtered.
The solvent was removed "by rotary evaporation and the residue distilled. 
The fraction hoiling at 156-156° C/2.5 mm was collected. The NMR was 
identical with that of Sadtler file number 6795 for n-dibutyl tartrate.
The yield on separate runs varied from 63-71$*
Be Synthesis of n-Butyl Glyoxalate
1021. Periodic Acid Method.
360 ml dry ether and U8 ml (0.2 mole) di-n-butyl tartrate 
were placed in a 3-necked round bottom flask in a nitrogen atmosphere.
The mixture was cooled in a water bath and stirred continuously.
4U.8 g (0.2 mole) periodic acid were added in portions over one hour.
The solution was stirred a few minutes more. The ether phase was 
decanted, dried over magnesium sulfate, filtered and evaporated. The
r Oresidue was distilled under vacuum and the portion boiling at 53-69 C/7 mm 
collected
1032. Lead Tetraacetate Method.
In a 250 ml, 3-necked round bottom flask, 100 ml dry benzene 
and 31 g di-n-butyl tartrate were placed under nitrogen and stirred 
rapidly. UU.5 g lead tetraacetate were slowly added over 25 minutes, 
keeping the temperature below 30°C with a cold water bath. The mixture 
was stirred one hour after addition was complete, during which time the
gummy salts turned crystalline. The salts were removed by suction 
filtration and washed with UO ml benzene. The solvent was removed by' 
distillation at 65°C/50 mm, and the residue distilled at 65-79°C/20 mm 
under nitrogen.
1013« Sodium Periodate Method.
72 ml di-n-butyl tartrate and 800 ml 0.^02 M sodium periodate 
were mixed in a 1 liter flask under nitrogen and stirred vigorously 
for one hour. The solution was extracted with ether, dried over mag­
nesium sulfate, filtered, the solvent evaporated, and the residue dis­
tilled under vacuum. The portion boiling at U8-53°C/7 mm was collected. 
Yields ranged from 7 -^83$. A strong NMR peak was observed at 69*0.
C. Grignard and Related Reagents: Preparation and Use.
Ethyl magnesium bromide and ethyl magnesium chloride were 
purchased from Yentron Chemical Company, Alfa Division, Cleveland, Ohio 
Ul*128e Methyl magnesium iodide was prepared by the method described 
below. Ethynyl magnesium halide was prepared from each of these
10Ureagents by the method of Jones, et al.
1. Lithium Aeetylide.1^
220 mM industrial grade acetylene were bubbled into 200 ml of 
tetrahydrofuran in a 500 ml 3-necked round bottom flask equipped with 
a sealed dropping funnel and a gas inlet and outlet. The system was 
kept in a nitrogen atmosphere at -78° throughout the reaction. 50 ml 
n-butyllithium were transferred to the dropping funnel and added to the 
reaction mixture over 20 minutes, then stirred 10 more minutes.
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2. Methyl Magnesium Iodide 
Methyl magnesium iodide was prepared by the method described
10l*by Jones, et al., for the preparation of ethyl magnesium bromide.
9 g magnesium turnings (Fisher Scientific Company) and about 30 ml 
tetrahydrofuran were placed in a dry 500 ml 3-necked round bottom flask 
equipped with a mechanical stirrer, reflux condenser and a pressure- 
equalizing dropping funnel. The entire apparatus was kept under nitro­
gen during the reaction. About 1 ml methyl iodide was added from the 
dropping funnel to initiate the reaction. When the reaction had begun, 
the rest of the tetrahydrofuran (2J0 ml) was added. 2k ml methyl iodide 
were added dropwise and rinsed in with a few ml of tetrahydrofuran.
The reaction was allowed to continue for two hours. A thick grey syrup 
formed.
10l*3. Ethynyl Magnesium Halide.
A 1 liter 3-necked round bottom flask was equipped with a 
sealed mechanical stirrer, a frittered glass disk gas inlet, a pressure 
equalizing dropping funnel, and a gas outlet. The entire system was 
flamed out under nitrogen. 500 ml of dry tetrahydrofuran were placed 
in the flask. (Use of less tetrahydrofuran resulted in some precipita­
tion of the product Grignard reagent; use of more tetrahydrofuran made 
the subsequent reaction easier.) Industrial grade acetylene was 
passed through a -80° trap, concentrated sulfuric acid, and an ascarite 
drying tube for cleaning, then into the tetrahydrofuran in the reaction 
vessel. When the solution was saturated with acetylene, the alkyl 
magnesium halide (130 ml of 2.9^ M ethyl magnesium bromide in ether 
for this amount of tetrahydrofuran) was slowly added in portions from
51*
the dropping funnel.. This addition took 2-3 hours. During the last 
part of the reaction, the mixture was warmed slightly (to about 30-^0°C) 
to insure complete dissolution of the Grignard Reagent for easy trans­
fer to a 500 ml dropping funnel for the subsequent reaction.
k. Butyl 2-Hydroxy-3-Butynoate.
JL06
a. From Ethynyl Magnesium Halide.
A 2 liter 3-necked round bottom flask was equipped with a 
magnetic stirring bar, a gas inlet, a 500 ml pressure-equilibrating 
dropping funnel and a gas outlet, all flamed out under nitrogen. The 
following reaction was kept under nitrogen until addition of the Grignard 
was completed. U7.0 g of n-butyl glyoxalate was added to the flask and 
rinsed in with 50-100 ml tetrahydrofuran. The flask was cooled to 
<_-20°C in a carbon tetrachloride/dry ice bath. Warm Grignard Reagent/ 
tetrahydrofuran solution (from part 3 above) was transferred to the 
dropping funnel. This mixture was added slowly to the cold solution 
with stirring. (.Directions in the literature called for addition over 
1/2 hour; we were never able to add the Grignard this fast while main­
taining an internal temperature <-20°C. A typical addition time was
1.5-2 hours. Best results were obtained on one run when the addition 
time was extended to more than 3 hours and the internal temperature 
remained <-30°C.) After addition was completed, the reaction mixture 
was allowed to warm to room temperature.
A mixture of 1 liter crushed ice, 30 g ammonium chloride and 
50 ml concentrated hydrochloric acid were added to hydrolize the 
reaction mixture. The organic layer was decanted and the aqueous layer
extracted with ether. The organic portions were combined, dr,ied over 
magnesium sulfate and filtered. The solvents were removed by rotary 
evaporator and the residue distilled. The portion boiling at 93-105° 
C/10 mm was collected.
IR: 3500, 2900 and 1150 cm-1(OH), 2100 (C=C)
NMR: 6.9, 1.5, ^.0 (Bu ester); <S2.U(HC=C), 5U.6(a-H); OH shift varies.
Yield averaged 30$. The product remains stable for at least a month
when stored at 5°C under nitrogen.
b. From Lithium Acetylide
11.b g (0.088 moles) n-butyl glyoxalate were transferred to 
the dropping funnel and added over 5 minutes. The reaction mixture was 
allowed to reach room temperature, then hydrolized with 0^ ml of water. 
Anhydrous potassium carbonate was added until the aqueous layer became 
pasty and the organic layer was then washed twice with 30 ml portions 
of ether. The organic layers were combined, dried over magnesium 
sulfate, filtered and the solvents removed. The residue was distilled 
at 9*5 mm pressure.
5. Ethyl 2-Keto-3-Butynoate.
Diethyl oxalate (Fisher Chemical Corporation) was distilled 
at 79-80°C/l0 mm and used in place of n-butyl glyoxalate in the above 
reaction with ethynyl magnesium bromide (III-C-U). A two molar excess 
of diethyl oxalate over Grignard was used to decrease the likelihood 
of double attack on any one molecule. The fraction boiling at 76-80°C/
9.5 mm upon distillation was collected. A strong IR acetylene peak was
observed at 2100 cm*"^ . The acetylenic proton had shifted to 63-85 in
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the NMR. HPLC analysis showed two components (starting diethyl oxalate 
and 2-keto-3-butynoate, ethyl ester). Comparison of the acetylenic peak 
weight to that for the -CH^- of the ethyl group gave a ratio of 
1:6.05 hy weight corresponding to a yield of 28$ of the keto ester.
1 rjQ
D. Synthesis of Butyl 2-Tosyl-3-Butynoate.
1076.7g of recrystallized tosyl chloride were dissolved in
3.7 ml pyridine and cooled quickly to obtain short crystals. 5g of 
butyl 2-hydroxy-3-butynoate were added to the tosyl chloride/pyridine 
mixture which was kept on ice. The mixture was stirred by hand, then 
transferred to a 10-20° water bath for one hour. This mixture turned a 
glassy wine color within 10 minutes, becoming very viscous and usually 
solidifying. The reaction vessel was then transferred back to the ice 
bath and 25 ml of water were slowly added. The aqueous solution was 
extracted with ether to a total volume of 125 ml. The ether extract 
was then back-washed with 150 ml 0.01 N sulfuric acid and 100 ml 2.5$ 
sodium bicarbonate. The ether solution was dried over magnesium 
sulfate, filtered, and the solvent evaporated. The tosylate crystallized 
on one attempt, but usually remained as an oily residue.
IR: 2100 cm ^ (,C=C) + varying amounts of 1950 cm"'*" (C-C=C); ll60,
1170 cm ■*" (tosyl group doublet).
NMR: 67.1-7-5 (phenyl H?s); 62.35 ((j)Me-masks acetylenic H);
6U.5 (CECCH).
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E. Preparation of Butyl 2-chloro-3-butynoate,
1. In Diethyl Ether with Pyridine.
Ten ml butyl 2-hydroxy-3-butynoate were stirred in 50 ml 
anhydrous ether in a 250 ml 3-necked round bottom flask in an ice 
bath, equipped with two pressure-equalizing dropping funnels. 6 ml 
thionyl chloride were placed in one dropping funnel and 6.35 ml pyridine 
in the other. These solutions were added simultaneously over 1/2 hour. 
Then 50 ml ice water were added, the organic layer decanted and the 
aqueous layer extracted with ether. The organic portions were combined, 
dried over magnesium sulfate, filtered, and the solvent evaporated.
The residue was distilled and a fraction boiling between 89-101°C/9.5 mm 
was collected.
—1 —1IR: decrease in 3600 cm and lUOO cm OH bands; sharp CHEC stretch
at 2100 cm \
NMR: 6U.7 (=C-CH(Cl)), 5U.5 (=C-CH(0H)), 62.6 (HC=C[CCl]),
62.3 (HC=C[C0H]).
NMR shows a mixture of starting alcohol and desired chloride in about 
a 60:^0 ratio, with respect to the relative heights of the above cited 
NMR peaks. Verny and Vessiere claim a yield of 95$ for this reaction; 
in our hands the yield never exceeded 50$, and the two products could 
not be separated by distillation with the equipment in our possession.
2. In Isopropyl Ether.
A mixture of 3 g (0.0192 moles) butyl 2-hydroxy-3-butynoate,
20 ml isopropyl ether and 0.02 ml thionyl chloride were refluxed for
two days under nitrogen, cooled and the solvent evaporated. There was 
insufficient material to distill the chloride away from polymerized 
by-products.
IR: 2100 cm  ^(C=C) and expected decrease in -OH bands.
NMR: 6i+.7 and 62.7 and absence of other acetylenic peaks indicated
the chloro rather than the hydroxy species is present.
HPLC: 3 peaks in the cleanest preparation. These peaks correspond to
three of the peaks in the distilled preparation of the mixture 
of the a-chloro and a-hydroxy esters (part (l) above).
F. Alumina Column Chromatography
Aluminum oxide (alumina) (Chemie-Ergeugnisse and Absorption- 
technik AG, Hombergerstrasse 2k 9 kl32 Muttenz, Schweitz) was activated 
by drying for two days at 210°, then stored in a dessicator. The dry 
alumina was poured into ether in a 2 cm column to a height of 16 inches. 
The column was washed with about 200 ml ether to insure complete set­
tling. U ml of sample were layered on the column and washed in with 
ether. 50 ml fractions were collected to a total of 1200 ml. Methanol 
was then rinsed through the column and 50 ml fractions again collected 
to a total of 1200 ml.
To restore the alumina, it was stirred in ethyl acetate and 
allowed to sit for two days, dried at 80°, then at 210° for two days.
Deactivated alumina was prepared by adding 10$ water to 
activated alumina.
G. Attempts to Prepare Butyl 2-Amino-3-Butynoate
1. With Ammonia"^ ^
59
a. Preparation of Cuperous Chloride111
8.5 g cuprous chloride dihydrate were dissolved in 25 ml of 
water and filtered into a 125 ml erienmeyer flask. 10 g copper wire 
were added and the mixture heated under nitrogen almost to boiling 
for 12 minutes. In the meantime, 10 ml ether and 300 ml water were 
mixed in a 1 liter erienmeyer flask, covered, shaken, and allowed to 
stand. The copper solution and white precipitate was then poured into 
the ether/water solution. The copper wire was rinsed with 10 ml of 
3N hydrochloric acid which was also added to the ether/water solution. 
This was allowed to settle for 10 minutes under nitrogen in the hood. 
The white crystals were collected on a buchner funnel. A thin film of 
liquid was kept over the crystals at all times. The crystals were 
rinsed with 2x10 ml ethyl alcohol, then 2x10 ml ether and spread on a 
watch glass to dry. When dry, the crystals were stored under nitrogen 
in a vial in a dissicator.
b. Preparation of Amine
1 ml concentrated ammonium hydroxide and a few grains of 
cuprous chloride were added to a flask containing VL ml butyl 2-tosyl- 
3-butynoate. The mixture was stirred at room temperature four hours. 
Then 5 ml ether plus 5 ml water were added to the reaction vessel and 
the entire contents transferred to a separatory funnel. The aqueous 
layer was extracted with ether, these extractions combined, dried over 
magnesium sulfate, filtered and the solvent evaporated. A white, flaky 
residue was left. m.p. = 123-^ .
—1 —1 IR: 1900 cm ( C = C = C ) • only minor 2100 cm (C=C) absorption;
36-3200 cm”1 triplet, 1600, 1U5O, 1300 cm”1 C-NHg).
6o
IR is'consistent with the formation of the allenic amine, butyl 2-amino- 
2,3-butadienoate.
2 * Cyanoborohydride on Ethyl 2-Keto-3-Butynoate.
In a modification of a method described by Borch, et al., for
112the preparation of a-amino acids, 20.0 g diethyl oxalate/2-keto-3- 
butynoate were added to a mixture of 16 g ammonium bromide and 3-2 g 
sodium cyanoborohydride in dry methanol. The mixture was stirred for 
U8 hours under nitrogen. (The yellow ketone solution turned orange 
within minutes after addition; the solution was light yellow at the end 
of incubation.) Concentrated hydrochloric acid was added to pH<2 and 
the methanol removed under vacuum. A white residue was obtained which 
was dissolved in about 100 ml of water and extracted with U.TO ml ether. 
The aqueous layer was made basic (pH>10) with potassium hydroxide and 
saturated with sodium chloride. This basic aqueous layer was extracted 
with 5x100 ml ether, dried over magnesium sulfa.te, filtered and evapo­
rated. The white residue collected from this fraction did not melt 
below 300°C and was probably salt.
If the amine ester had been hydrolized to the zwitterionic 
acid, it would not dissolve in ether at this high pH but rather at its 
isoelectric point. Therefore the basic aqueous layer was neutralized 
(most simple neutral amino acids have their isoelectric points at pH 
6-7) s and extracted with ether. The ether extracts were combined, 
dried over magnesium sulfate, filtered and the ether evaporated.
NMR: 62.1 (-CH^, 63.k (-CHg-), 6k.6 broad (7-NHg)
IR: 3300-3^00 cm~^ broad, 2980, 2900 cm*-^
6l
The acid extracted ether fraction was also dried and analyzed.
IR: broad absorbance with little detail, 3600-2300 cm \  peaks at
1750, 1^50, 1330, and a doublet at 1220 cm \
NMR: a complicated spectrum that could not be analyzed.
3. Grabriel Synthesis 
113a. Preparation of the phthalimide
1*.0 g of 2-tosyl-3-butynoate were mixed with 5«75 g potassium- 
phthalimide salt (Eastman Chemical Company, Rochester, N.Y. 1U650),
16 ml dimethyl formamide and 1 crystal potassium iodide and refluxed
1.5 hours. (The mixture quickly thickened and turned black.) Where 
refluxing was finished, 25 g ice were added and the solid material 
(brown-black crystals) was collected by suction filtration. These 
crystals were dissolved in 225 ml chloroform, washed with 3x33 ml IN 
potassium hydroxide, 3x33 ml 0.5N hydrochloric acid and 3x33 ml water. 
The chloroform was then evaporated. 1.6 g of a black oil remained.
IR: 2100 cm’"1 (C=C); 2900, 1700-1750 cm"1 (C=0); 1^50, 1370, 1270,
1200, 1060 cm 1 (phthalimide).
NMR: 58.k broad, 8.15 sharp (ArH); 62.2 (HC=C); 6U.55 (?CNH).
ikhb. Hydrazinolysis of the phthalimide
Crude phthalimide from part a above was rinsed into a 50 ml 
round bottom flask with 20 ml 95% ethanol. 2.2 g hydrazine hydrate 
were added and the mixture was refluxed one hour. After it had cooled,
3.7 ml 10N hydrochloric acid were added to the solution which was kept 
cool on ice. The resulting precipitate was collected by suction
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filtration and triturated with 20 ml water, filtered again and the 
combined filtrates evaporated to dryness. The residue was treated with 
a solution of U.U g potassium hydroxide in 10 ml water and extracted 
with 5x6 ml ether. The ether extract, was dried over potassium hydroxide 
and filtered. The ether was removed by distillation through a column 
of glass beads. The residue was insoluble in carbon tetrachloride.
IR: broad 3500 and l600 cm 1 peaks indicative of either acid or amine;
no 1200 or 800 cm 1 peak as expected for a secondary amine.
H. Hydrolysis
1151. Alkaline.
1.8 g (0.032 moles) potassium hydroxide were dissolved in 
80 ml water and mixed with 5 g (0.032 moles) butyl 2-hydroxy-3-butynoate. 
This solution was stirred overnight at room temperature. Concentrated 
hydrochloric acid was then added until a test drop of the solution 
turned Congo Red paper blue. This addition was carried out in an ice 
bath. The solution was then extracted with ether and the ether extract 
dried over magnesium sulfate, filtered and the solvent distilled. NMR 
analysis showed that hydrolysis did not take place.
2. Acidic
2.7 g butyl 2-hydroxy-3-butynoate and 50 ml 10% hydrochloric 
acid were mixed and refluxed four hours. The solution was concentrated 
under vacuum and put on ice but crystallization could not be induced.
The solution was therefore extracted with ether and the ether extract 
dried over magnesium sulfate, filtered and the solvent removed under
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vacuum. An impure oily acid remained. HPLC analysis showed two major 
components with small quantities of a number of other components also 
present. This material could not be recrystallized from hexane.
1173. Transesterification
A mixture of 3 g (0.0192 moles) butyl 2-hydroxy-3-butynoate,
8 ml acetic acid and k ml concentrated hydrochloric acid were refluxed
1.5 hours in the hood, and allowed to cool. The solution was concen­
trated in an oil bath at 100°/50 mm and cooled. 33 ml of saturated 
sodium bicarbonate solution were added to the residue and the mixture 
stored overnight at 5°C.
When warmed to room temperature the solution was brought to 
neutral pH with additional solid sodium bicarbonate and extracted with 
2x11 ml ether. The aqueous solution was then acidified with 12N sulfuric 
acid. (This addition was done slowly in an ice bath as a great deal 
of heat and frothing was produced.) The oily suspension was extracted 
with 3x12 ml ether. The ether extracts were combined and washed with 
water, dried over magnesium sulfate, filtered and the ether evaporated. 
The oily residue was insoluble in carbon tetrachloride and had the 
broad 3600-3000 cm"1 IR absorption expected for acids. The 2100 cm 1 
C=C stretch was also observed.
Where the above hydrolysis was performed on fractions contain­
ing butyl 2-chloro-3-butynoate the residue from the acidic ether extract 
was dissolved in 18.5 ml warm (50-60°) concentrated hydrochloric acid 
and the solution allowed to cool with occasional swirling. The 
hydrochloric acid was then removed under vacuum. The resulting residue 
was subjected to HPLC analysis and used in enzyme inhibition studies.
6k
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I. Enzyme Assays-Irreversible Inhibition
1. Inhibition
a. Solutions
i. 0.02M pyrophosphate buffer, pH 8.3. 
k.k65g sodium pyrophosphate decahydrate were diluted to 10 ml with 
water and adjusted to pH 8.3 with 6N hydrochloric acid.
ii. Catalase, U mg/ml.
O.OOlj-Og catalase (ICN Pharmaceuticals, Inc. Life Sciences Group, 
Cleveland, Ohio UU128) were weighed out and diluted to 10 ml with 
water the day of use.
iii. FAD, 2.8x10 M.
0.0022g FAD (Flavin Adenine Dinucleotide) (ICN Pharmaceuticals, Inc.
Life Sciences Group, Cleveland, Ohio UU128) were weighed out and diluted 
to 10 ml with buffer. This solution was kept in the dark at all times.
iv. DAAO, 6.25 Ug/ml
0.0005g DAAO (U.S. Biochem Corp., Cleveland, Ohio UU128) were weighed 
out and dissolved in 0.U ml FAD solution plus 7*6 ml buffer. This 
solution was prepared just before use and kept in the dark.
v. Inhibitor
Amounts as described in Results and Discussion were weighed out and 
diluted with buffer.
Vi. TCA, 30% w/v 
7g TCA (trichloracetic acid) were diluted to 25 ml with water.
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b„ Procedure
Solution A was prepared by mixing 2 ml FAD solution, 2 ml 
catalase and 8 ml buffer. O.U ml of this solution A was added to each 
of 15 test tubes. 0.5 ml DAAO was added to each of the first 1^ test 
tubes and 0.5 ml buffer to the last (the blank). The test tubes were 
allowed to equilibrate in a constant temperature bath of 3T°C. 1 ml
of inhibitor was added to each odd numbered tube and 1 ml of buffer to 
each even numbered tube. One tube each of inhibitor and buffer solu­
tions was incubated for exactly 1, 59 10, 20, 50, 100 and 120 minutes.
At the end of the incubation period, 0.3 ml D-alanine was added to the 
tube and the solution incubated for another 20 minutes. At the end of 
this period 0.5 ml TCA was added to stop all further enzyme activity.
2. Pyruvate Assay
a. Solutions
i. 1 M hydrochloric acid saturated with 
2,^-dinitrophenyl hydrazine (DNPH)
k6 ml DNPH were ground with an increasing volume of 1 M HCL to a total 
volume of 50 ml.
ii. 2 M Sodium Hydroxide
UOg sodium hydroxide were dissolved in water and diluted to 500 ml.
The solution was allowed to cool before being used.
b. Procedure
To each of 15 test tubes 0.9 ml water and 0.2 ml DNPH solu­
tion were added, then 0.1 ml of killed enzyme solution from part 1 above. 
Exactly 15 minutes after addition of the enzyme solution the incubation
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was stopped by adding 3.0 ml of 2.0M sodium hydroxide. The absorbance 
at 525 nm was measured within 1/2-hour.
III. RESULTS AND DISCUSSION
A. Preparation of Butyl-2-Hydroxy-3-Butynoate
a-hydroxy butynoic acid has been found to be an inhibitor of
99DAAO. Its ester is a useful intermediate whose hydroxy group can be
replaced by a number of other functional groups. Therefore it was
prepared as the starting material for a number of projects. Because
106the reported yield in the standard synthetic procedure was only 
- 30%, considerable initial effort was spent searching for a method that 
would give a higher yield.
1. Preparation of n-Butyl Glvox&iate
Initial work was done on redistilled n-dibutyl tartrate found 
in the stockroom. Little or no n-butyl glyoxalate could be generated 
via any of the procedures described. Careful re-examination of the 
NMR data for this starting material showed an extra peak at 62.3. 
Although other physical properties of this material appeared to match 
those for n-dibutyl tartrate, every other possible error in the syn­
thesis was systematically eliminated. When starting with dibutyl 
tartrate we had synthesized ourselves, good yields of the n-butyl 
glyoxalate were obtained.
The best yields of n-butyl glyoxalate were obtained from the 
reaction with sodium periodate (Section III-B-3). This reaction was
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also the easiest to perform. Therefore, this procedure was followed 
preferentially whenever the reagents were available.
There was some discrepancy in the liter ature"^^ as to 
the actual boiling point of the aldehyde. We found that the best frac­
tion, by NT© analysis, was the cut boiling between U8 and 58°C/7 mm.
2. Preparation of Butyl 2-Hydroxy-3-Butynoate
Because the reported yield for butyl 2-hydroxy-3-butynoate,
via the Grignard reaction was only 30$, initial attempts were made to
find a substitute means of adding the acetylenic functional group bo
the aldehyde end of n-butyl glyoxalate. Lithium acetylide-ethylene
diamine complex has been used in the laboratory to add acetylene to
118other compounds in good yield. Therefore addition with this reagent 
was tried first. A method similar to that described for the ethynyl- 
magnesium halide addition (Section II-C-U) was used. The only product 
isolated from the ether extraction was n-butanol. Subsequent extraction 
Of the aqueous layer with tetrahydrofuran yielded a carbon tetrachloride 
insoluble component. Therefore, it appears that this reagent hydro- 
lizes the ester rather than adding acetylene to the aldehyde end of 
the molecule.
105Midland has described a procedure for the preparation of 
ethynyl carbinols and terminal acetylenes from aldehydes and ketones 
using monolithium acetylide at low temperatures. In our hands, using 
n-butylglyoxalate, none of the desired acetylene could be isolated.
It should be noted, however, that this reaction was never repeated 
after the aldehyde preparation was satisfactorily worked out and may 
yet provide a means of significantly improving the yield at this step.
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The addition of a terminal acetylene to n-butyl glyoxalate
106by the method of Verny and Vessiere using ethynyl magnesium bromide 
was repeated consistently in this laboratory in the yields reported 
(30$ average) and became the accepted route to the 2-hydroxy-3-butynoate, 
butyl ester.
When ethyl magnesium chloride was substituted for ethyl 
magnesium bromide in the systhesis, a much lower yield was obtained.
Both ethyl magnesium chloride and ethynyl magnesium chloride were 
significantly less soluble in tetrahydrofuran than the corresponding 
bromo compounds and were therefore much more difficult to work with.
■It was uncertain whether the decrease in the amount of product formed 
•was due to a decreased reactivity of the ethynyl magnesium chloride or 
simply to its being less soluble.
It was felt that since the chloride was less soluble than 
the bromide in tetrahydrofuran, the corresponding iodides ought to be 
more soluble and more reactive, providing a higher yield of the acety- 
lide hydroxy ester. Ethynyl magnesium iodide was therefore prepared 
and used in this reaction. It formed a thick grey slush rather than 
the expected solution. When distillation of the residue from ether 
extraction of the reaction mixture was attempted, a dark brown-black 
material filled the distillation apparatus at a temperature of about 
l*0°C/9 .5 mm. None of the desired product could be collected.
Varying amounts of polymerized by-product were obtained in 
all Grignard reactions depending upon the type of Grignard used, the 
temperature during addition, and the pressure during distillation. Once 
the hydroxy ester was distilled away from this mixture, however, it 
could be redistilled without appreciable polymerization.
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B. Preparation of Butyl 2-Tosyl-3-Butynoate
A series of 3-butynoic acids, substituted in the a-position 
are desired for inhibition studies on DAAO. Therefore, one would like 
to find an intermediate which can be the common precursor to all these 
products. Because the tosyl group is such a good leaving group, it 
was hoped that the tosylate would become such an intermediate. Pre-
108paration of the tosy late by the method of Eglinton and Whiting, 
developed especially for use on acetylenic compounds, was very straight­
forward. However, the tosylate was unstable, rearranging first to the 
allene, then loosing its unsaturation with time. (Within l6 hours 
under refrigeration, almost all the acetylene had disappeared; within 
3 days no unsaturation could be detected.) In one preparation only the 
acetylene peak was observed by IR immediately after preparation; usually 
both the acetylene and allene peaks were present. The tosylate was,.. 
therefore always prepared immediately prior to its use in subsequent 
reactions.
When it was determined that unsaturation was being lost in
tosylate prepared by the above method, an attempt was made to use the
107method for tosylate synthesis described by Fieser and Fieser. No 
acetylenic tosylate could be isolated. A search of the literature 
indicated that the presence of pyridine (of which a much larger con­
centration is used in the latter procedure) increases the likelihood 
of rearrangement of the acetylenic moiety to the allene which is sus­
ceptible to attack by nucleophiles and that this might be the cause of 
unsaturation loss.^^*^^ Eglinton and Whiting"*’^  found a marked de­
crease in tosylate production when the amount of pyridine was increased,
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supporting this theory. In light of these problems, an attempt was
made to synthesize the tosylate in a non-pyridine medium. When the
120method of Prib and Malinovskii for propargyl esters, using ether
as the solvent, was employed, most of the acetylene was again lost
with some allene and significant double bond formation as judged by
both NMR and IR analysis. Since no better method could be found, that
iodof Eglinton and Whiting for the preparation of 2-tosyl-3-butynoate 
was used for all synthetic work.
C. Preparation of Butyl 2-Chloro-3-Butynoate
1. Synthesis
Because of the instability of the 2-tosyl-3-butynoate, a
great deal of time was spent trying to prepare a pure sample of 2-chloro-
3-butvnoate as an alternative intermediate. This compound is also
interesting in its own right as a potential inhibitor of DAAO.
i o^SYerny and Vessiere prescribed two methods for the prepara­
tion of this chloride, neither of which proved very satisfactory in our 
hands. They reported a 67$ recovery of esters consisting of 95$ of 
the a-chloro ester and 9% of the a-hydroxy ester when using method 
II-E-1; we were never able to achieve better than 30% conversion. Using 
method II-E-2, they obtained a 55$ yield consisting solely of the a- 
chloro ester; we obtained a small amount of the a-chloro ester (as 
determined by NMR) plus mostly polymerization by-products.
2. Separation of Butyl 2-Chloro-3-Butynoate from 
Butyl 2-hydroxy-3-Butynoat e
Since the overall yield from method II-E-1 was much better 
than that for method II-E-2, we concentrated on trying to separate the
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a-chloro and a-hydroxy esters using column chromatography on alumina.
We chose alumina column chromatography for separation of the two ester 
species because other chloro and hydroxy compounds had previously 
been successfully separated by alumina column chromatography in this 
laboratory.'*'1®
The esters boiled within k° of each other and hence could not 
be separated by distillation. The acetylenic moiety partially rearranges 
to an allene during gas chromatography. The HPLC preparative column 
available to us at the time could not separate large quantities of 
material. Therefore, we felt the alumina column offered the best poten­
tial for separation of these two species.
We were hoping to be able to separate the two esters and there­
by obtain the a-chloro ester in pure form for subsequent preparative 
work. The chloroester should go right through an alumina column when 
applied and eluted with ether. Then changing the solvent to methanol 
should elute the hydroxy ester. Preliminary work with a mixture of 
n-butyl chloride and n-butyl hydroxide verified these column charac­
teristics. 50 ml fractions were collected during elution with first 
1200 ml of ether, then 1200 ml of methanol and the contents of these 
fractions were monitored by gas chromatography (GC). The GC spectra 
indicated that a much more complicated process than the expected one 
was taking place. When ether fractions 2 and 3 were combined and eva­
porated, an IR spectrum indicated that partial hydrolysis and partial 
to full rearrangement to the allene had taken place. The multiple 
peaks in the GC spectra were apparently from the sum of these rearrange­
ment products and the products of rearrangements known to take place
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106during GC analysis . Methanol fractions from these columns showed 
equally complicated spectra. These fractions were never completely 
analyzed.
109Farrar, et al. have described the hydrolysis of esters on 
activated alumina columns and recommended deactivating the columns by 
adding 10$ water to the alumina. They claimed this eliminated all 
hydrolysis by alumina of the esters they were working with. When we 
prepared a column in this manner, the flow rate was extremely slow and 
IR analysis indicated the same partial hydrolysis and partial rearrange­
ment to the allene as before. Perhaps the added length of time the 
ester was exposed to the column counteracted the decreased activity of 
the alumina.
Due to the above described complications in separation of the 
a-chloro ester by distillation and chromatography a pure sample of 
a-chloro butynoate was never obtained for further preparative work.
Future separations of butyl 2-hydroxy-3-butynoate and butyl 
2-chloro-3-butynoate should by done on the preparative HPLC now avail­
able in this laboratory since analytical HPLC analysis of this mixture 
resulted in easy separation of the esters in methanol:water solutions 
with no apparent rearrangement taking place.
D. Attempts to Make 2-Amino-3-Butynoate
1. Using Ammonia
Monroe et al.11  ^claim to have prepared 2-amino-3-butynoic 
acid for use as a corrosion retardant. They obtained the amine from 
the corresponding a-chloro-acid. We were never able to prepare the 
a-chloro-acid in sufficient purity to use as a preparative reagent.
However, the tosyl ester proved to be quite easy to make although it 
also easily rearranged to the allene. We attempted to use the tosylate 
in the prescribed procedure, to prepare butyl 2-amino-3-butynoate, but 
were only able to isolate what IR analysis indicated was the allenie 
amine, butyl 2-amino-2,3-butadienoate. At the time these reactions 
were run, we were not interested in the allenie amine and did nothing 
with those products. In light of subsequent inhibition studies (discussed 
elsewhere in this work), however, purification of this allenie amine 
and inhibition studies with it might prove very interesting.
the synthesis of a-aminobutynoate failed in our hands, a complete search 
of the literature was made for other possible pathways. Two distinctly 
different possibilities presented themselves: Cyanoborohydride attack
on an a-keto acid and the well-known Gabriel synthesis.
for synthesis of the amine from the ketoester. Cyanoborohydride re-
1
duces an iminium ion much faster than it reduces a carbonyl group:
2. The Cyanoborohyde Reaction
When the only preparation described in the literature for
The cyanoborohydride reagent seemed like an attractive reagent
^)c=o + NaCNBI
(2U)
NaBH-CN
(b)
Reduction of the carbonyl group is negligible under neutral conditions 
and must be run in a system buffered at pH 3-^ . These reactive pro­
perties of cyanoborohydride allow one to aminate an aldehyde or ketone
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by simply reacting the carbonyl compound with amine at pH 6-8 in the 
presence of sodium cyanoborohydride:
•nl p3 ©  -p-1- p3
s c=o + mi'' CNBn3 S x ch— n '' (25)
r2' V
This reaction is general for aldehydes, and unhindered ketones with
121ammonia, primary and secondary amines.
A further attraction of this reagent is that it does not react 
112 121 123with ester or acid groups. * 5 Broch, et al. have used this
112method to synthesize six of the common amino acids. It is a par-
1kticularly convenient method for preparing N labeled ammo acids.
Although some a,3~unsaturated compounds show a tendency toward
12 *^ 1261,1* attack and bond migration, ” and the allenie derivative of
121a-aminobutynoate should be readily reduced via its enamine form,
"Vo TT®
i II H v !!
HoC=C=C-C0Et \ HoC=CH-C-C0oEtd initial reversible 2 2
protonation occurs 
up to pH 8 ©
^NBH3 (26)
N
I
H2C=CH-CHC02Et
Examination of the literature indicated that the acetylenic function
122 127 might be left intact. *
Therefore, we prepared ethyl-2-keto-3-butynoate in order
to attempt to repalce the keto group with an amine.
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a. Ethyl 2-Keto-3-Butynoate
The idea for the actual reaction used in this synthesis came
128from the work of I. I. Lapkin and Y. S. Andreichikov who first 
succeeded in preparing a series of a-keto acetylenic esters. Ethyl 2- 
keto-U-pheny1-3-butynoate was reported in a 20% yield from ethyl 
magnesium bromide, phenyl acetylene and diethyl oxalate using different 
conditions from ours. We felt that the method we had for the preparation 
of an a-hydroxy acetylenic ester was at least as good as the method 
reported for this synthesis and ought to give the desired a-oxo ester 
if diethyl oxalate were substituted for n-butyl glyoxalate in reaction 
II-C-l*a. In order to avoid attack by a second Grignard on the keto ester, 
leading to the diacetylenic alcohol, a 2:1 ratio of diethyl oxalate: 
Grignard was used.
From planimeter measurements of the relative peak heights 
for the acetylenic H and the methylenyl H, a yield of 50% of the keto 
ester was calculated. When the sample was subjected to HPLC (high 
pressure liquid chromatography) analysis, only two components were 
observed, the excess starting material, diethyl oxalate, and ethyl 2- 
keto-3-butynoate. From the relative weights of these two peaks a yield 
of 28% was calculated. This is a much more accurate measurement than 
the planimeter measurement of the HMR peaks as the NMR peaks were small 
and sharp and difficult to measure accurately. Even this lower yield 
is considerably better than the 20% yield reported by Lapkin and 
Andreichikov for a related compound.
The acetylenic proton was shifted downf ield in the NMR by the 
a-keto ester. We observed it at 63-9 instead of near 62.35 as observed
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for the a-hydroxy ester. This large shift downfield is apparently due
to the intense electron ■withdrawing nature of the a-keto ester. Jouve 
129
and Lecomte have studied the 6 shift for the acetylenic H in a 
series of a-substituted species. These studies showed that the more 
the electron withdrawing character adjacent to the acetylenic moiety, 
the stronger the 6 shift downfield. Their values ranged from 61.60 for 
MeC=CH to 63.0 for MeC0C=CH_. The addition of the ester group 3 to the 
acetylene apparently increases this shift significantly. Jouve and 
Lecomte also correlated the increase in the shift toward higher 6 in 
the NMR with an increase in the amplitude of the IR peak. We did indeed 
observe a much stronger acetylenic peak in the IR for this compound.
One can also explain this shift in terms of resonance struc­
tures. If one considers the possible resonance structures that can be 
written for this species:
©
0 0  ^ 0 0
II II x  ©  I I!
HC= C-C-COEt ----> HC=C=C -> COEt (27)
a b
In accordance with this decrease in triple bond character both the 
HC=C 6 in M R  and the C=C stretch in the IR are shifted toward that 
expected for a double bond. The shift for a vinylic proton in NMR is 
6k.6-5.9, this proton has been shifted from 2,35 to 3-9- The allenie 
stretch in the IR is at 1950 era the stretch in this molecule has 
moved from the expected 2100 cm  ^to 2060 cm” .^
This compound appears to be quite stable. HPLC work was not 
done until two months after the synthesis was complete, yet showed only
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the two expected components. Repeat NMR and IR analysis five months 
after synthesis gave the same spectra except that the HC=C NMR peak had 
shifted upfield to 63.6.
b. The Cyanoborohydride Reaction
No product could be isolated from the ether extract of the 
basic aqueous solution of the cyanoborohydride reaction. Thus the amine 
ester, butyl 2-amino-3-butynoatemust not have been formed. If the 
ester had been hydrolized during this reaction however, it would no 
longer be insoluble in base and could only be extracted near its 
isoelectric point. Since most neutral amine acids have their isoelectric 
points between pH 6 and 7S the aqueous layer was neutralized and reex­
tracted with ether. The NMR spectra of the residue left when the ether 
was evaporated was not inconsistent with the 2-amino-3-butynoate struc­
ture still in the ester form, but IR shows no carbonyl stretch at 
1700-1800 cm ■*". It is unlikely that an acid was formed since the 
material was soluble in carbon tetrachloride.
When the ether extract of the material originally dissolved 
in water before being made basic was examined by NMR and IR, it appeared 
to be composed of a number of products and could never be analyzed.
3. The Gabriel Synthesis
The Gabriel Synthesis has been used to prepare amines from
130a variety of halo compounds. In particular, amines have been
131successfully prepared from both ot-halo esters and propargylic 
113halides in good yields. Therefore we were hopeful that 2-amino-3- 
butynoic acid, which contained both of these functional groups, could 
be synthesized by this method.
The Gabriel Synthesis is a 2-step preparation consisting 
of initial reaction with potassium phthalimide to form the addition 
phthalimide plus water, and subsequent acid hydrolysis or hydrazinolysis 
to the amine.
a* Preparation of Butyl 2-Phthalimide-3-Butynoate
Assuming the acetylinic group to be the one most prone to give
us difficulties, we followed the reaction procedure described for
1132-butynylchloride. It is interesting to note that although the
tosyl starting material contained both allenie and acetylenic absorp­
tion peaks in the IR, only a clean acetylenic peak was observed for the 
phthalimide.
Although a large amount of brown-black crystals were obtained
from the water solution after reflux, only 1.6g (a 33% yield) of a
black oil were left after the described work-up procedure had been
followed. If this reaction is to become a significant step on the
pathway to the a-amino butynoic acid, then a better work-up procedure
needs to be found. When preparing l,U-diphthalimide but-2-yne, Fraser 
132and Raphael simply washed the precipitated solid obtained when water 
is added to the refluxed mixture with cold water and used it in the 
next step. They were also able to recrystallize this material from 
acetic acid. These modifications may be sufficient in our ca,se. Cer­
tainly a good yield of precipitate was obtained from water in our case 
and if it could be used without further purification, a much higher 
yield of the product amine should be obtained.
Examination of the IR and NMR data indicated that the 
phthalimide had indeed been prepared.
b. Hyarazinolysis of Butyl 2-Phthalimido-3-Butynoate
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The hydrazinolysis was performed by a method used to produce
N-crotyl amine from the phthalimide, again under the assumption that
a method successful for an unsaturated system was most likely to give
us our desired unsaturated amine. However examination of the IR of the
product of this reaction showed only a faint trace of the 2100 cm ^
acetylene peak. No allene absorption was observed. The spectrum
showed the broad absorbance at 3500  ^and 1600  ^indicative of an amine,
but the expected 1200 and 800 cm  ^peaks were missing. The product was
insoluble in carbon tetrachloride and the NMR spectrum in heavy water
...indicated that the butyl group had been lost. This was not a problem
for our purposes as we wished to produce the acid ultimately. However,
no* acetylenic peak could be observed in the NMR. The NMR spectrum was
not inconsistent with the product's being 2-aminobutyric acid.
Although this hydrozinolysis step was unsuccessful in this
'initial trial, the Grabriel Synthesis appears to hold promise as a route
to a-aminobutynoate. The phthalimide reaction was successful and there
are a variety of ways to remove this functional group. All early work
with phthalimides involved hydrolyzing the phthalimide in refluxing 
130acid. We have shown the acetylenic group to be stable to refluxing
ll6acid. However, it may be that the a,8-un saturated bond will be 
susceptible to saturation under any of the required preparative condi­
tions .
E. Hydrolysis
Several different hydrolysis techniques were tried on butyl
2-hydroxy-3-‘butynoate. Mild basic hydrolysis yielded only starting
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material. Acid hydrolysis gave the acid in a mixture of products (as 
determined by IR and HPLC). Transesterification gave the best results 
although HPLC data still showed a number of components in the residue.
This method was used to generate all acids for use in enzyme studies.
Both butyl 2-hydroxy-3-butynoate and butyl 2-chloro-3-butynoate were 
oils under these conditions and no means was ever found of inducing them 
to crystallize.
F. Enzyme Inhibition
1. Chloro Compound
Although a pure 2-chloro-3-butynoic acid fraction could never 
be prepared, it was decided to run preliminary inhibition studies on 
the mixture containing this species (Inhibitor, path 1, scheme III).
Then if no inhibition were found, we would not waste valuable time 
trying to purify it. However, when this mixture was tested it exhibited 
powerful time-dependent inhibition essentially stopping all enzyme 
activity within 20 minutes. A repeat run one month later gave similar 
results (Fig. 6). When a second preparation containing purer 2-chloro-
3-butynoic acid according to IR analysis (Inhibitor, path 2, scheme III) 
was tested, no time-dependence could be observed and inhibition was not 
complete.
In order to determine where the inhibitory species first 
appeared in the preparative procedure, a third sample was prepared, 
testing for inhibition at each step (path 3, scheme III). That is, 
tests were performed on the mixture of 2-hydroxy-3-butynoate and 2-chloro-
3-butynoate,butyl esters before column chromatography, the first ether 
fractions from the column and the product of hydrolysis. The end
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product displayed the same qualities as the product of the second pre­
paration. Only the product directly off the column, which has been 
shown to be a combination of partia,lly hydrolized chloro compounds, 
primarily the a-chloro allene, shows time-dependent inhibition. However 
the inhibition only decreased to 37$* Presumably this was because the 
inhibitor was present only in small quantities, insufficient to react 
with the full amount of enzyme present. In this test the inhibition 
had nearly reached its maximum after only 5 minutes.
To determine which component in the original (path l) inhibi­
tor fraction was the powerful inhibitor of DAAO, we separated this 
fraction into 3 components by preparative HPLC using 20:80 methanol: 
water as the solvent and a 2ml/min. flow rate to separate a 1.5 ml 
injection sample. Three components were isolated and tested for inhibi­
tion. All 3 components were inhibitors of DAAO; the first and third 
displaying non-time dependent inhibition, and the second one showing 
time-dependent, but less strong inhibition. None of these species alone 
displayed the powerful inhibition properties of the mother liquor. 
Perhaps the powerful time-dependent inhibition is due to some type of 
symbiotic relationship in the interaction of this combination of 
inhibitors with DAAO.
Scheme III is a flow chart showing how each inactivating 
species was prepared and the results it gave. In interpreting the data 
given in scheme III it is important to recognize that the reported 
inhibitor concentrations are unreliable because we had some difficulty 
making sure the solvent was completely removed in every case and 
because the inhibitor fractions were, in most cases, not a pure
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substance. Therefore, absolute numbers for the degree of inhibition 
are not reliable; only the general inhibition characteristics can be 
considered significant. Furthermore, one must be aware that the phrase 
"non time-dependent inhibition" means that inhibition had reached its 
maximum before the first measurement, after one minute of incubation, 
was made. Thus "non time-dependent inhibition" could be either rapid 
(<1 min.) time-dependent inhibition or true non time-dependent inhibi­
tion. These reactions are run at large inhibitor concentrations, and 
it is possible, that time dependence might be observed as inhibitor 
concentration decreased.
samples that did not inhibit DAAO in an observably time-dependent manner,
this species (2-chloro-3-butynoic acid) was ruled out as the "time-
dependent" inhibitor.
Vessiere and Verny have shown that esters of 2-chloro-3-
butynoate easily isomerize to their allenie isomers, 2-chloro-2,3- 
106butadienoate. Where the crude allenie material was left several
days at room temperature, crystals separated out which, upon analysis,
133were found to be:
Since the acetylenic peak was present to a greater degree in
Cl
C02Et
Qk
It is possible that we observed a similar dimerization and that the 
inhibiting species is the mono-acid of the butyl ester dimer:
/P“20„BuACl
1\\/;
\
C02H
However, if this were the case, one would expect more inhibition from 
the hydrolysate of path 2 (see scheme III) where the allene is known to 
have been present in large quantity. Confirmation of the structures 
of the observed inhibitors awaits Fourier Transform NMR analysis.
2. Oxalate Inhibition
Because 2-keto-3-butynoate was interesting as the ester
form of a potential inhibitor of the reduced enzyme, 2-keto-3-butynoic
acid, we wished to run a preliminary test on its inhibitory qualities
before hydrolysis. However, it was still in solution with the starting
material, diethyl oxalate. Therefore, a test was first run on diethyl
oxalate to make sure any inhibitory qualities we saw were not due to
this compound. Much to our surprise, we found strong inhibition by
k
this species. A 10 molar excess of this inhibitor over enzyme reduced
the observed enzyme activity to 15% • No time-dependence was observed.
57Freisell et al. tested a large number of compounds for 
DAAO inhibition and concluded that the essential features for inhibi­
tion were C=C-X ®  where X ®  was a carboxylate or phenolic hydroxyl
group and C=C could be part of an aliphatic, aromatic or heterocyclic 
structure. The saturated analogues of these species did not inhibit 
DAAO. The compounds they tested were competitive rather than irrever­
sible inhibitors. Dianionic species such as fumarate and malonate 
exhibited no inhibition. However Dixon and Kleppe observed inhibition 
by straight chain fatty acids. They also tested a-hydroxy and a-keto 
acids and found them to exhibit inhibition properties. From their work 
it was concluded that (l) the R group provides most of the affinity 
for the enzyme with a chain length having optimum binding ability 
and (2) the a-amino group is not essential for binding.
Oxalic acid has been found to be an inhibitor of lactate 
oxidase #^-3^-136 Qxalic acid is isoelectronic with the normal substrate 
anion for lactate oxidase:
<\®/c
vs
/ - A
° ' © ' °
\ ® /c
R' ^  OH
This similarity allows for initial binding of the pseudo-substrate 
which then inhibits the enzyme by decarboxylation and alkylation of 
the flavin N(5).
Diethyloxalate should not be an inhibitor for DAAO since it 
contains no acid group for binding at the active site. But esters 
have never been tested as possible inhibitors for DAAO since an 
anionic group (the carboxylic acid) has always been presumed to be 
necessary for initial substrate binding.
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The monoacid, ethyloxate would he a much more likely inhibi­
tor of DAAO. It is analogous to normal oxidized substrate:
© ©
V °V/°
C C
i vs *c c
y  \  y \
EtO 0 R m
and as such might form a very strong complex with the reduced enzyme.
Some inhibitors (e.g., the propargyiglycine derivative (8) of scheme I)
act9have been shown to inhibit after reduction of the enzyme. EtOCCOH
would be most likely to react in this manner. The following acyl sub­
stitution can be envisioned to take place with reduced enzyme.
N N
t-> EtO-C-COOH ----> C-COOH
EtO-C-jjOH /OH 0&
(28)
+EtOH
The presence of the leaving group, -OEt, provides a means of obtaining 
a stable adduct. To test this hypothesis the mono-acid would have to 
be specifically prepared and tested for inhibition. If irreversible 
inhibition were found, then the inhibited portion of the enzyme would 
have to be isolated and identified to see if it were indeed the proposed 
species.
IV. CONCLUSIONS AND PROPOSALS FOR FURTHER STUDY
This series of studies on the preparation of derivatives of 
a-substituted-3-butynoates and preliminary tests for inhibition by 
them have shown that these species are indeed inhibitors of DAAO and 
warrant further study.
Three new compounds have been made during the course of this 
study: ethyl 2-keto-3-butynoate, butyl 2-tosyl-3-butynoate and butyl 
2-phthalimido-3-butynoate. Each of these species was prepared as an 
intermediate for further synthetic work and was never fully character­
ized in its own right. The structure of each species was consistent 
with IR and NMR analysis.
Ethyl 2-keto-3 ^-butynoat e appears to be a very stable species
(no degeneration was observed during five months of storage). Mass
spectrophotometry and elemental analysis should be done to confirm
the assignment of this species. The acid analogue of 2-keto-3-butynoate
93has been reported to be a highly unstable species which had to be 
generated in situ enzymatically for enzyme studies. This instability 
could be tested by hydrolysis of ethyl 2-keto-3-butynoate, If the 
acid does not decarboxylate, enzyme inhibition studies should be per­
formed with this acid since it is an oxidized substrate analogue.
Butyl 2-tosyl-3-butynoate is an unstable species which 
rapidly rearranges into its allenie analogue, butyl 2-tosyl-2,3-buta- 
dienoate, and, more slowly, into a saturated compound. Conditions for
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optimizing the production and lifetime of this compound need to be found 
to improve its use as an intermediate in a variety of substitution 
reactions.
Butyl 2-phthalimido-3-’butynoate has been prepared, but the 
work-up procedure that was followed resulted in the loss of most of the 
product. Some possible improvements in the work-up procedure were 
suggested. These should be tried along with any other alterations in 
the procedure that might improve the yield.
The hydrazinolysis of this compound described in this thesis 
did not yield the expected 2-amino-3-butynoate, but the procedure up to 
this step is sufficiently promising, that some effort should be spent 
trying to find proper hydrazinolysis conditions. Some possible changes 
were discussed in Section III of this text.
2-Hydroxy-3-butynoate is the starting intermediate for all 
the synthetic work described in this thesis. This compound could only 
be prepared in a Grignard Reaction with a 30% yield. A possible alter­
native method was described. The yields reported in the literature for 
addition of lithium acetylide to aldehydes is sufficiently high (~90%)^^ 
to justify some effort to get this reaction to work with butyl 
glyoxalate.
A mixture of 2-hydroxy-3-butynoate and 2-chloro-3-butynoate 
was separated, hydrolysed and tested for inhibition. A powerful inhibi­
tor of DAAO was found which has been separated into three different 
fractions, each displaying unique inhibition properties. Possible 
identities of these species have been presented; definitive assignments 
of structures for them will require Fourier Transform NMR analysis 
because they are available in only minute quantities. It is hoped that
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assignment of structure to inhibitor species will lead to a better 
understanding of the effects of an acetylenic group vs. an allenie 
group in DAAO inhibition. A method was described which led to prepara­
tion of butyl-2-amino-2,3-dienoate. This compound should again be 
prepared, and hydrolyzed and tested for inhibition to give additional 
information on inhibition by an allenie species.
The inhibition studies described in this thesis are only 
preliminary. For those species displaying "non time-dependent" inhibi­
tion, competitive inhibition studies should be performed. All species 
should be tested at several lower concentrations to determine the amount 
of inhibitor necessary for inactivation and to determine the inhibition 
kinetics. Substrate protection should also be tested. The inhibited 
enzyme should then be tested for irreversibility of the inhibition— are 
there conditions under which the activity can be revived? The position 
of the irreversible bond between the enzyme and inhibitor should then 
be determined. This is usually done by reacting radioactive inhibitor 
with the enzyme, then isolating the radioactive fraction from degra­
dation experiments. Identification of the nature of the enzyme—  
inhibitor bond can then be used to determine the mode of inactivation 
involved and thus a likely intermediate in the enzyme reaction. If 
this bond has been shown to be at the active site, then isolation of 
this portion of the enzyme can elucidate at least part of the enzyme 
active site.
Diethyl oxalate was also shown to be an inhibitor of DAAO 
at sufficiently large concentrations (85% inhibition at 10^:1 I:E; no 
inhibition at 1:1 I:E). The inhibiting species was postulated to be
90
the mono-acid, ethyloxalate. This compound should be prepared to test 
for enzyme inhibition to confirm this theory. Since inhibition by this 
compound was "non time-dependent", competitive inhibition studies should 
also be performed. If irreversible inhibition is found, then character­
ization of the inhibited species should be undertaken as described above. 
Further work on these inhibitors and related compounds can be very fruit­
ful. Characterization of the different inhibitor species and the types 
of inhibition they cause can lead to a greater understanding of inter­
mediate steps in enzyme catalysis and the nature of the enzyme active 
site. In particular, it appears that significant differences between 
inhibition by acetylenic vs. allenic substrate analogues can be shown.
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CH20fj»-0H
(CHOH)
FMN
9 9
C H gO f-O -p-O C H
(CHOH)
OH OH
The Isoalloxazine Ring
FAD
Fig. 1. The two biological forms of the flavin coenzyme. FMN = flavin 
mononucleotide. FAD = flavin adenine dinucleotide. The 
isoalloxazine ring portion of the coenzyme is at the enzyme 
active site.
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Fig, 2. The oxidized, semiquinone and reduced states of flavin 
and their absorption maxima.
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Fig. U. The geometry of oxidized and reduced flavin.
(a) Planar Oxidized Flavin.
(b) Planar Reduced Flavin, with an 8tt antiaromatic central ring.
(c) Reduced Flavin in the normal butterfly configuration.
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35Fig. 5« Orbital overlap for a carbanion-flavin adduct.
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Fig. 6. Inhibition of DAAO by hydrolysate from Path I, Scheme III.
A = freshly prepared inhibitor. • = after 1 month's storage.
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